<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE sequence-cwu SYSTEM "us-sequence-listing-v1_3-2020-10-08.dtd" [ ]><sequence-cwu id="SEQLST-1"><publication-reference><document-id><country>US</country><doc-number>20230002780</doc-number><kind>A1</kind><date>20230105</date></document-id></publication-reference><number>1</number><sequence-list-new-rules><s100><s160>24</s160></s100><s200><s210>1</s210><s211>2115</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 1ccatggctaa taagcacctc tcactctccc tgttcctcgt cctcctcggg ctctccgcct     60ccctcgcctc gggggttcag ctccctcctg cctacaccaa ctccttcacg cgcggcgtgt    120actaccccga caaggtcttc aggtccagcg tgctgcactc cacgcaggac ctcttcctgc    180cgttcttcag caacgtgacc tggttccacg ccatccacgt cagcggcacc aacggcacga    240agcgcttcga caacccggtg ctgcccttca acgacggcgt ctacttcgcg tccaccgaga    300agagcaacat catcaggggc tggatcttcg gcaccacgct cgactccaag acgcagagcc    360tcctgatcgt gaacaacgcc accaacgtgg tcatcaaggt ctgcgagttc cagttctgca    420atgacccctt cctgggcgtg tactaccaca agaacaacaa gtcctggatg gagagcgagt    480tccgcgtgta ctccagcgcg aacaactgca cgttcgagta tgtgtcccag ccgttcctca    540tggacctgga gggcaagcag ggcaacttca agaacctccg cgagttcgtc ttcaagaaca    600tcgacggcta cttcaagatc tactccaagc acaccccgat caacctggtg agggacctcc    660cacagggctt cagcgctctg gagcccctgg tggacctccc catcggcatc aacatcaccc    720gcttccagac gctcctggct ctgcacagga gctacctcac cccaggcgac tcgtcctcgg    780gctggacggc cggcgcggcc gcctactacg tgggctacct gcagccgcgc accttcctcc    840tgaagtacaa cgagaacggc acgatcaccg acgccgtgga ctgcgctctg gacccactct    900cggagaccaa gtgcacgctg aagagcttca ccgtcgagaa gggcatctac cagacgtcca    960acttccgcgt gcagccgacc gagagcatcg tcaggttccc gaacatcacg aacctctgcc   1020ccttcggcga ggtgttcaac gcgaccaggt tcgcctccgt ctacgcctgg aaccgcaaga   1080ggatctccaa ctgcgtcgcc gactacagcg tgctctacaa cagcgcgtcc ttcagcacct   1140tcaagtgcta cggcgtgtcc ccgacgaagc tgaacgacct ctgcttcacc aacgtctacg   1200ccgacagctt cgtgatccgc ggcgacgagg tcaggcagat cgctccgggc cagacgggca   1260agatcgccga ctacaactac aagctgccgg acgacttcac cggctgcgtg atcgcgtgga   1320actccaacaa cctcgacagc aaggtcggcg gcaactacaa ctacctgtac cgcctcttca   1380ggaagtccaa cctgaagccc ttcgagcgcg acatctccac ggagatctac caggcgggca   1440gcaccccctg caacggcgtg gagggcttca actgctactt cccgctccag agctacggct   1500tccagccaac caacggcgtg ggctaccagc cgtacagggt ggtcgtgctc tccttcgagc   1560tgctccacgc ccccgctacc gtgtgcggcc ccaagaagag caccaacctc gtcaagaaca   1620agtgcgtgaa cttcaacttc aacggcctga ccggcacggg cgtgctcacc gagtccaaca   1680agaagttcct gcccttccag cagttcggca gggacatcgc ggacacgacc gacgcggtca   1740gggacccaca gaccctggag atcctcgaca tcaccccctg ctccttcggc ggcgtcagcg   1800tgatcacccc cggcaccaac acgagcaacc aggtcgcggt gctgtaccag gacgtgaact   1860gcacggaggt ccccgtggcc atccacgctg accagctgac gcccacctgg agggtgtact   1920ccaccggcag caacgtcttc cagacgaggg cgggctgcct catcggcgcc gagcatgtca   1980acaacagcta cgagtgcgac atcccgatcg gggcgggcat ttgcgcttcc taccagacac   2040agacgaactc cccacggcgg gcttgatagt taacctagac ttgtccatct tctggattgg   2100ccaacttaat taatg                                                    2115</s400><s200><s210>2</s210><s211>2127</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 2ccatggctaa taagcatctg tctctctcac tcttcctcgt cctcctcggg ctctcagcgt     60ctctcgcctc aggggtccag ctcccaccgg cctacaccaa ctccttcacg cgcggcgtgt    120actaccccga caaggtcttc aggtccagcg tgctgcactc cacgcaggac ctcttcctgc    180cgttcttcag caacgtgacc tggttccacg ccatccacgt cagcggcacc aacggcacga    240agcgcttcga caacccggtg ctgcccttca acgacggcgt ctacttcgcg tccaccgaga    300agagcaacat catcaggggc tggatcttcg gcaccacgct cgactccaag acgcagagcc    360tcctgatcgt gaacaacgcc accaacgtgg tcatcaaggt ctgcgagttc cagttctgca    420atgacccctt cctgggcgtg tactaccaca agaacaacaa gtcctggatg gagagcgagt    480tccgcgtgta ctccagcgcg aacaactgca cgttcgagta tgtgtcccag ccgttcctca    540tggacctgga gggcaagcag ggcaacttca agaacctccg cgagttcgtc ttcaagaaca    600tcgacggcta cttcaagatc tactccaagc acaccccgat caacctggtg agggacctcc    660cacagggctt cagcgctctg gagcccctgg tggacctccc catcggcatc aacatcaccc    720gcttccagac gctcctggct ctgcacagga gctacctcac cccaggcgac tcgtcctcgg    780gctggacggc cggcgcggcc gcctactacg tgggctacct gcagccgcgc accttcctcc    840tgaagtacaa cgagaacggc acgatcaccg acgccgtgga ctgcgctctg gacccactct    900cggagaccaa gtgcacgctg aagagcttca ccgtcgagaa gggcatctac cagacgtcca    960acttccgcgt gcagccgacc gagagcatcg tcaggttccc gaacatcacg aacctctgcc   1020ccttcggcga ggtgttcaac gcgaccaggt tcgcctccgt ctacgcctgg aaccgcaaga   1080ggatctccaa ctgcgtcgcc gactacagcg tgctctacaa cagcgcgtcc ttcagcacct   1140tcaagtgcta cggcgtgtcc ccgacgaagc tgaacgacct ctgcttcacc aacgtctacg   1200ccgacagctt cgtgatccgc ggcgacgagg tcaggcagat cgctccgggc cagacgggca   1260agatcgccga ctacaactac aagctgccgg acgacttcac cggctgcgtg atcgcgtgga   1320actccaacaa cctcgacagc aaggtcggcg gcaactacaa ctacctgtac cgcctcttca   1380ggaagtccaa cctgaagccc ttcgagcgcg acatctccac ggagatctac caggcgggca   1440gcaccccctg caacggcgtg gagggcttca actgctactt cccgctccag agctacggct   1500tccagccaac caacggcgtg ggctaccagc cgtacagggt ggtcgtgctc tccttcgagc   1560tgctccacgc ccccgctacc gtgtgcggcc ccaagaagag caccaacctc gtcaagaaca   1620agtgcgtgaa cttcaacttc aacggcctga ccggcacggg cgtgctcacc gagtccaaca   1680agaagttcct gcccttccag cagttcggca gggacatcgc ggacacgacc gacgcggtca   1740gggacccaca gaccctggag atcctcgaca tcaccccctg ctccttcggc ggcgtcagcg   1800tgatcacccc cggcaccaac acgagcaacc aggtcgccgt gctgtaccag gacgtgaact   1860gcacggaggt ccccgtggcc atccacgctg accagctgac gcccacctgg agggtgtact   1920ccaccggcag caacgtcttc cagacgaggg cgggctgcct catcggcgcc gagcatgtca   1980acaacagcta cgagtgcgac atcccgatcg gcgcgggcat ctgcgcttca taccagactc   2040agacaaactc tccacggcgg gctaaggacg agctgtgata gttaacctag acttgtccat   2100cttctggatt ggccaactta attaatg                                       2127</s400><s200><s210>3</s210><s211>2151</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 3ccatggctaa taagcacctc tccctgtctc tcttcctcgt cctcctgggg ctctctgcct     60cgctcgcctc tggggttcag ctcccgcctg cctacaccaa ctccttcacg cgcggcgtgt    120actaccccga caaggtcttc aggtccagcg tgctgcactc cacgcaggac ctcttcctgc    180cgttcttcag caacgtgacc tggttccacg ccatccacgt cagcggcacc aacggcacga    240agcgcttcga caacccggtg ctgcccttca acgacggcgt ctacttcgcg tccaccgaga    300agagcaacat catcaggggc tggatcttcg gcaccacgct cgactccaag acgcagagcc    360tcctgatcgt gaacaacgcc accaacgtgg tcatcaaggt ctgcgagttc cagttctgca    420acgacccctt cctgggcgtg tactaccaca agaacaacaa gtcctggatg gagagcgagt    480tccgcgtgta ctccagcgcg aacaactgca cgttcgagta tgtgtcccag ccgttcctca    540tggacctgga gggcaagcag ggcaacttca agaacctccg cgagttcgtc ttcaagaaca    600tcgacggcta cttcaagatc tactccaagc acaccccgat caacctggtg agggacctcc    660cacagggctt cagcgctctg gagcccctgg tggacctccc catcggcatc aacatcaccc    720gcttccagac gctcctggct ctgcacagga gctacctcac cccaggcgac tcgtcctcgg    780gctggacggc cggcgcggcc gcctactacg tgggctacct gcagccgcgc accttcctcc    840tgaagtacaa cgagaacggc acgatcaccg acgccgtgga ctgcgctctg gacccactct    900cggagaccaa gtgcacgctg aagagcttca ccgtcgagaa gggcatctac cagacgtcca    960acttccgcgt gcagccgacc gagagcatcg tcaggttccc gaacatcacg aacctctgcc   1020ccttcggcga ggtgttcaac gcgaccaggt tcgcctccgt ctacgcctgg aaccgcaaga   1080ggatctccaa ctgcgtcgcc gactacagcg tgctctacaa cagcgcgtcc ttcagcacct   1140tcaagtgcta cggcgtgtcc ccgacgaagc tgaacgacct ctgcttcacc aacgtctacg   1200ccgacagctt cgtgatccgc ggcgacgagg tcaggcagat cgctccgggc cagacgggca   1260agatcgccga ctacaactac aagctgccgg acgacttcac cggctgcgtg atcgcgtgga   1320actccaacaa cctcgacagc aaggtcggcg gcaactacaa ctacctgtac cgcctcttca   1380ggaagtccaa cctgaagccc ttcgagcgcg acatctccac ggagatctac caggcgggca   1440gcaccccctg caacggcgtg gagggcttca actgctactt cccgctccag agctacggct   1500tccagccaac caacggcgtg ggctaccagc cgtacagggt ggtcgtgctc tccttcgagc   1560tgctccacgc ccccgctacc gtgtgcggcc ccaagaagag caccaacctc gtcaagaaca   1620agtgcgtgaa cttcaacttc aacggcctga ccggcacggg cgtgctcacc gagtccaaca   1680agaagttcct gcccttccag cagttcggca gggacatcgc ggacacgacc gacgcggtca   1740gggacccaca gaccctggag atcctcgaca tcaccccctg ctccttcggc ggcgtcagcg   1800tgatcacccc cggcaccaac acgagcaacc aggtcgcggt gctgtaccag gacgtgaact   1860gcacggaggt ccccgtggcc atccacgctg accagctgac gcccacctgg agggtgtact   1920ccaccggctc caacgtcttc cagacgaggg cgggctgcct catcggcgcc gagcacgtca   1980acaactccta cgagtgcgac atccccatcg gcgcgggcat ctgcgccagc taccagaccc   2040agacgaactc acccaggagg gctttctacc cgtcttacca tagcacaccc cagcggcctt   2100gatgattaac ctagacttgt ccatcttctg gattggccaa cttaattaat a            2151</s400><s200><s210>4</s210><s211>2424</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 4ccatggctaa taagcatctg tccctgtccc tgttcctggt cctcctgggg ctctcagcgt     60ccctcgcctc cggggttcag ctccctccag cctacaccaa ctccttcacg cgcggcgtgt    120actaccccga caaggtcttc aggtccagcg tgctgcactc cacgcaggac ctcttcctgc    180cgttcttcag caacgtgacc tggttccacg ccatccacgt cagcggcacc aacggcacga    240agcgcttcga caacccggtg ctgcccttca acgacggcgt ctacttcgcg tccaccgaga    300agagcaacat catcaggggc tggatcttcg gcaccacgct cgactccaag acgcagagcc    360tcctgatcgt gaacaacgcc accaacgtgg tcatcaaggt ctgcgagttc cagttctgca    420acgacccctt cctgggcgtg tactaccaca agaacaacaa gtcctggatg gagagcgagt    480tccgcgtgta ctccagcgcg aacaactgca ccttcgagta tgtgtcccag ccgttcctca    540tggacctgga gggcaagcag ggcaacttca agaacctccg cgagttcgtc ttcaagaaca    600tcgacggcta cttcaagatc tactccaagc acaccccgat caacctggtg agggacctcc    660cacagggctt cagcgctctg gagcccctgg tggacctccc catcggcatc aacatcaccc    720gcttccagac gctcctggct ctgcacagga gctacctcac cccaggcgac tcgtcctcgg    780gctggacggc cggcgcggcc gcctactacg tgggctacct gcagccgcgc accttcctcc    840tgaagtacaa cgagaacggc acgatcaccg acgccgtgga ctgcgctctg gacccactct    900cggagaccaa gtgcacgctg aagagcttca ccgtcgagaa gggcatctac cagacgtcca    960acttccgcgt gcagccgacc gagagcatcg tcaggttccc gaacatcacg aacctctgcc   1020ccttcggcga ggtgttcaac gcgaccaggt tcgcctccgt ctacgcctgg aaccgcaaga   1080ggatctccaa ctgcgtcgcc gactacagcg tgctctacaa cagcgcgtcc ttcagcacct   1140tcaagtgcta cggcgtctcc ccgacgaagc tgaacgacct ctgcttcacc aacgtctacg   1200ccgacagctt cgtgatccgc ggcgacgagg tcaggcagat cgctccgggc cagacgggca   1260agatcgccga ctacaactac aagctgccgg acgacttcac cggctgcgtg atcgcgtgga   1320actccaacaa cctcgacagc aaggtcggcg gcaactacaa ctacctgtac cgcctcttca   1380ggaagtccaa cctgaagccc ttcgagcgcg acatctccac ggagatctac caggcgggca   1440gcaccccctg caacggcgtg gagggcttca actgctactt cccgctccag agctacggct   1500tccagccaac caacggcgtg ggctaccagc cgtacagggt ggtcgtgctc tccttcgagc   1560tgctccacgc ccccgctacc gtgtgcggcc ccaagaagag caccaacctc gtcaagaaca   1620agtgcgtgaa cttcaacttc aacggcctga ccggcacggg cgtgctcacc gagtccaaca   1680agaagttcct gcccttccag cagttcggca gggacatcgc ggacacgacc gacgcggtca   1740gggacccaca gaccctggag atcctcgaca tcaccccctg ctccttcggc ggcgtcagcg   1800tgatcacccc cggcaccaac acgagcaacc aggtcgcggt gctgtaccag gacgtgaact   1860gcacggaggt ccccgtggcc atccacgctg accagctgac gcccacctgg agggtgtact   1920ccaccggctc caacgtcttc cagacgaggg cgggctgcct catcggcgcc gagcacgtca   1980acaactccta cgagtgcgac atccccatcg gcgcgggcat ctgcgcctcc taccagacgc   2040agaccaacag cccacgcagg gcggccccgc agtccatcac ggagctgtgc agcgagtacc   2100acaacaccca gatctacacg atcaacgaca agatcctctc ctacaccgag agcatggccg   2160gcaagaggga gatggtcatc atcaccttca agtcgggcgc caccttccag gtggaggtgc   2220ccggctccca gcacatcgac agccagaaga aggccatcga gcgcatgaag gacaccctga   2280ggatcacgta cctcaccgag acgaagatcg acaagctctg cgtttggaac aacaagacac   2340ctaactctat tgctgcgatt tcgatggaga actgatgatt aacctagact tgtccatctt   2400ctggattggc caacttaatt aata                                          2424</s400><s200><s210>5</s210><s211>72</s211><s212>DNA</s212><s213>Hordeum vulgare</s213></s200><s400> 5atggcgaaca agcacctgag ccttagcctc ttcctcgtgc tcctgggcct ctccgcctcc     60ctcgcctccg gc                                                         72</s400><s200><s210>6</s210><s211>24</s211><s212>PRT</s212><s213>Hordeum vulgare</s213></s200><s400> 6Met Ala Asn Lys His Leu Ser Leu Ser Leu Phe Leu Val Leu Leu Gly1               5                   10                  15Leu Ser Ala Ser Leu Ala Ser Gly            20</s400><s200><s210>7</s210><s211>36</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 7ttctacccct cctaccacag caccccacag cgcccc                               36</s400><s200><s210>8</s210><s211>309</s211><s212>DNA</s212><s213>Escherichia coli</s213></s200><s400> 8gccccgcagt ccatcaccga gctctgctcc gagtaccaca acacccagat ctacaccatc     60aacgacaaga tcctctccta caccgagagc atggccggca agcgcgagat ggtgatcatc    120accttcaagt ccggcgccac cttccaggtg gaggtgccgg gctcccagca catcgactcc    180cagaagaagg ccatcgagcg catgaaggac accctccgca tcacctacct caccgagacc    240aagatcgaca agctctgcgt gtggaacaac aagaccccga actccatcgc cgccatcagc    300atggagaac                                                            309</s400><s200><s210>9</s210><s211>103</s211><s212>PRT</s212><s213>Escherichia coli</s213></s200><s400> 9Ala Pro Gln Ser Ile Thr Glu Leu Cys Ser Glu Tyr His Asn Thr Gln1               5                   10                  15Ile Tyr Thr Ile Asn Asp Lys Ile Leu Ser Tyr Thr Glu Ser Met Ala            20                  25                  30Gly Lys Arg Glu Met Val Ile Ile Thr Phe Lys Ser Gly Ala Thr Phe        35                  40                  45Gln Val Glu Val Pro Gly Ser Gln His Ile Asp Ser Gln Lys Lys Ala    50                  55                  60Ile Glu Arg Met Lys Asp Thr Leu Arg Ile Thr Tyr Leu Thr Glu Thr65                  70                  75                  80Lys Ile Asp Lys Leu Cys Val Trp Asn Asn Lys Thr Pro Asn Ser Ile                85                  90                  95Ala Ala Ile Ser Met Glu Asn            100</s400><s200><s210>10</s210><s211>3002</s211><s212>DNA</s212><s213>Zea mays</s213></s200><s400> 10cggtatgaat ttggaaacaa attcagtact tttaaaaaaa tttgttgtag ggagcaaata     60atacataaaa taatttatgc attattttat tttttatttg taataatatg cttgaaacga    120taattcagta tgcatgttgt gccagtgtac tacacgggcg gggggagggg attgagtggg    180ccagcgcggt gcgtagggta gatgggctga aattgataac tcaagtccga ctaggttctc    240tttttatttc ccttcctttt ctattttcct ttcttttaat tttcatgctt tcaaactaaa    300ttcaaattcg agttttgaat ttcagcttct aaattgtaca ctaaaattat atgataaggt    360aacccctact attactttta atttttttat tctaccccat attgtttact taggggagaa    420taattgactt aatcacattc ttcctaggtt tcaattctca atctttcaaa tccacatttt    480tagatttcta ttttgaattt aaataccagt ttggatttag agttcaattt caaaatacac    540aaccaaaata ccagcatgaa tgcaaatata ttttatgttt atgtatttac ttttctttta    600tactttgctc aaaatagtta ttttcatgta tgaaactcaa taagcaagga actcacgtta    660ttatataacc taataggaat aatttaggta acataattta tcatcctctt gatttaaaag    720agatatgcct ccagaataag acacatacta aaaataactc taatattgaa taactaaagt    780cgtacaaatc tctactatta ttcctataaa ataataaaga actagctaca acttctttaa    840ggcattattc agggtttaca gcttgagagg catgaaccca tcctgtatac tcctggactt    900ggaagacaaa atgtcaacca aagtgaaagg ttttcttatg gttgctgcta agagatagat    960tgaacactag atctctccta agacgtcagg gcatgcgttt agactcctac acatgcgaaa   1020actgcatctt acagttggaa gaaactatat ctcaccactt cctgcggtgt aactttgccc   1080aaagatgttg gctcactgtt ggaatcactc cgccccgaac tttggatcta acgcttgcag   1140tgctacatat tagagcaaga ctaacaatgc cgtggagaat ggaaggtatt ataaccatgt   1200catggtgcat atggaaatgt cgaaataact ggatattcga aaacataccg ccaacggtgg   1260cggcctgcaa ggaaatgttc aagactgaaa tgaactacat ctgctaccaa gttaagctcg   1320agacaggagc taaaagtaga aactggatac aacactttgt aacatagtga cactcccctt   1380ttcctttctt ttaccttaga actatacata caatccacat tcaataaaaa tttgtaggta   1440cgccatacac actaccggaa tccggctctt tgccgagtgt gaggcgcttt gtcgagtgct   1500ttttgtccag cactcggcaa aaaagtcttt gccatgtgcc gcactcggca aagtcctgct   1560ctcggtaacg accgcgttta ccgagagcag gactctcgac acagaaatac actcgacaaa   1620gaaatctttg ccgagagcca aacactcggc gaacggcagc gctcggcaaa gggtcgtcag   1680ccgccgtcta aagctgacgg tcgttatctt tgtcgagtgc cccctcgtcc gacactcagt   1740agagcaagct tgccgagtgc catccttgga cactcgataa agtatatttt attttttttt   1800attttgccaa ccaaactttt tgtggtatgt tcctacacta tgtagatcta catgtaccat   1860tttggcacaa ttacaaaaat gttttctata actattagat ttagttcgtt tatttgaatt   1920tcttcggaaa attcacatat gaactgcaag tcactcgaaa catgaaaaac cgtgcatgca   1980aaataaatga tatgcatgtt atctagcaca agttacgacc gaattcagaa gcagaccaga   2040atcttcaagc accatgctca ctaaacatga ccgtgaactt gttatccagt tgtttaaaaa   2100ttgtataaaa cacaaataaa gtcagaaatt aatgaaactt gtccacatgt catgatatca   2160tatatagagg ttgtgataaa aatttgataa tgtttcggta aagttgtgac gtactatgtg   2220tagaaaccta agtgacctac acataaaatc atagagtttc aatgtagttc actcgacaaa   2280gactttgtca agtgtccgat aaaaagtatt cagcaaagaa gccgttgtcg atttactgtt   2340cgtcgagatc tctttgccga gtgtcacact aggcaaagtc tttacggagt gtttttcagg   2400ctttgacact cggcaaagcg ctcgattcca gtagtgacag taatttgcat caaaaatagc   2460cgagagattt aaaatgagtc aactaataga ccaactaatt attagctatt agtcgttagc   2520ttctttaatc taagctaaaa ccaactaata gcttatttgt tgaattacaa ttagctcaac   2580ggaattctct gttttttcta taaaaaaaag ggaaactgcc cctcatttac agcaaactgt   2640ccgctgcctg tcgtccagat acaatgaacg tacctagtag gaactctttt acacgctcgg   2700tcgctcgccg cggatcggag tcccaggaac acgacaccac tgtggaacac gacaaagtct   2760gctcagaggc ggccacaccc tggcgtgcac cgagccggag cccggataag cacggtaagg   2820agagtacggc gggacgtggc gacccgtgtg tctgctgcca cgcagccttc ctccacgtag   2880ccgcgcggcc gcgccacgta ccagggcccg gcgctggtat aaatgcgcgc cacctccgct   2940ttagttctgc atacagccaa cccaacacac acccgagcat atcacagtga cagacactac   3000ac                                                                  3002</s400><s200><s210>11</s210><s211>2520</s211><s212>DNA</s212><s213>Zea mays</s213></s200><s400> 11gcgctccctg acgctgtctt gggagagctg caagatgaga cactccatcc cgcgcagccc     60tgtcgtggcg tcctcctgga tggacacctg catcgctgtc gccctccacc aactcacctg    120aacgaagaat agaataaaaa atggagggag ctgagggggc agtggttgcg ctgtagggag    180gagagagacc gcgtcattat aagactatct gcaaccgtta cctctaaatt tttccctcta    240tatcattttt tccccatatt ttccccccta ttttttcatc tcccgcaacg gtttctccta    300aatactcccc ctatatctca ctaccactat aaaatattat tttttatacc aactatcaat    360tttttatcta ctaacaatta ctcgtggacc cacagcacag tgtttaggag atgaacagtg    420acacgctata tctgggggga gagagaaaga ggccggcgcg tagggggcgc cgtaggggca    480ctgctgcggc tgtagagtac cccctacacg ccgcatgcaa gggaaggggg ctgtcagggg    540ggcaatgttg cgcatagcct aaagagcgga tgaagcggct tgcaatttgc acgctggatt    600cataaatagt gcatattact aaaaaaaagg gtggggatag gtatagagag tctattagag    660ttgatctaag acccggttta tttcagatta taatctgtcc ggattatata atccagcgca    720aataatacag taggtaaaca aacaactaga ttatgggttc agattatata atctaaaccc    780cagattatga taatctcata atctcctcaa gagtagctta ttggagatta ttttggcaaa    840agacccacta cccatggtta tgtaaataga aattataata tatatcatct tttttctcac    900cttaaataaa caaataaggg tattgttgtc tttatgaata atctacattt gtataatcta    960aactaccaaa caactacatc tagattataa tctggattat ataatttaaa ttataatcta   1020gattatataa tttataagct gaaacaaccc ggccctaaag cactatcgta tcacctatct   1080gaaataagtc acgggtttcg aacgtccact tgcgtcgcac ggaattgcat gtttcttgtt   1140ggaagcatat tcacgcaatc tccacacata aaggtttatg tataaactta catttagctc   1200agtttaatta cagtcttatt tggatgcata tgtatggttc tcaatccata taagttagag   1260taaaaaataa gtttaaattt tatcttaatt cactccaaca tatatggatt gagtacaata   1320ctcatgtgca tccaaacaaa ctacttatat tgaggtgaat ttggatagaa attaaactaa   1380cttacacact aagccaatct ttactatatt aaagcaccag tttcaacgat cgtcccgcgt   1440caatattatt aaaaaactcc tacatttctt tataatcaac ccgcactctt ataatctctt   1500ctctactact ataataagag agtttatgta caaaataagg tgaaattatg tataagtgtt   1560ctggatattg gttgttggct ccatattcac acaacctaat caatagaaaa catatgtttt   1620attaaaacaa aatttatcat atatcatata tatatatata aaccgtagca atgcacgggc   1680atataactag tgcaacttaa tacatgtgtg tattaagatg aataagaggg tatccaaata   1740aaaaacttgt tcgcttacgt ctggatcgaa aggggttgga aacgattaaa tctcttccta   1800gtcaaaattg aatagaagga gatttaatct ctcccaatcc ccttcgatca tccaggtgca   1860accgtataag tcctaaagtg gtgaggaaca cgaaacaacc atgcattggc atgtaaagct   1920ccaagaattt gttgtatcct taacaactca cagaacatca accaaaattg cacgtcaagg   1980gtattgggta agaaacaatc aaacaaatcc tctctgtgtg caaagaaaca cggtgagtca   2040tgccgagatc atactcatct gatatacatg cttacagctc acaagacatt acaaacaact   2100catattgcat tacaaagatc gtttcatgaa aaataaaata ggccggacag gacaaaaatc   2160cttgacgtgt aaagtaaatt tacaacaaaa aaaaagccat atgtcaagct aaatctaatt   2220cgttttacgt agatcaacaa cctgtagaag gcaacaaaac tgagccacgc agaagtacag   2280aatgattcca gatgaaccat cgacgtgcta cgtaaagaga gtgacgagtc atatacattt   2340ggcaagaaac catgaagctg cctacagccg tctcggtggc ataagaacac aagaaattgt   2400gttaattaat caaagctata aataacgctc gcatgcctgt gcacttctcc atcaccacca   2460ctgggtcttc agaccattag ctttatctac tccagagcgc agaagaaccc gatcgacacc   2520</s400><s200><s210>12</s210><s211>6510</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 12ggcgcgccgg tatgaatttg gaaacaaatt cagtactttt aaaaaaattt gttgtaggga     60gcaaataata cataaaataa tttatgcatt attttatttt ttatttgtaa taatatgctt    120gaaacgataa ttcagtatgc atgttgtgcc agtgtactac acgggcgggg ggaggggatt    180gagtgggcca gcgcggtgcg tagggtagat gggctgaaat tgataactca agtccgacta    240ggttctcttt ttatttccct tccttttcta ttttcctttc ttttaatttt catgctttca    300aactaaattc aaattcgagt tttgaatttc agcttctaaa ttgtacacta aaattatatg    360ataaggtaac ccctactatt acttttaatt tttttattct accccatatt gtttacttag    420gggagaataa ttgacttaat cacattcttc ctaggtttca attctcaatc tttcaaatcc    480acatttttag atttctattt tgaatttaaa taccagtttg gatttagagt tcaatttcaa    540aatacacaac caaaatacca gcatgaatgc aaatatattt tatgtttatg tatttacttt    600tcttttatac tttgctcaaa atagttattt tcatgtatga aactcaataa gcaaggaact    660cacgttatta tataacctaa taggaataat ttaggtaaca taatttatca tcctcttgat    720ttaaaagaga tatgcctcca gaataagaca catactaaaa ataactctaa tattgaataa    780ctaaagtcgt acaaatctct actattattc ctataaaata ataaagaact agctacaact    840tctttaaggc attattcagg gtttacagct tgagaggcat gaacccatcc tgtatactcc    900tggacttgga agacaaaatg tcaaccaaag tgaaaggttt tcttatggtt gctgctaaga    960gatagattga acactagatc tctcctaaga cgtcagggca tgcgtttaga ctcctacaca   1020tgcgaaaact gcatcttaca gttggaagaa actatatctc accacttcct gcggtgtaac   1080tttgcccaaa gatgttggct cactgttgga atcactccgc cccgaacttt ggatctaacg   1140cttgcagtgc tacatattag agcaagacta acaatgccgt ggagaatgga aggtattata   1200accatgtcat ggtgcatatg gaaatgtcga aataactgga tattcgaaaa cataccgcca   1260acggtggcgg cctgcaagga aatgttcaag actgaaatga actacatctg ctaccaagtt   1320aagctcgaga caggagctaa aagtagaaac tggatacaac actttgtaac atagtgacac   1380tccccttttc ctttctttta ccttagaact atacatacaa tccacattca ataaaaattt   1440gtaggtacgc catacacact accggaatcc ggctctttgc cgagtgtgag gcgctttgtc   1500gagtgctttt tgtccagcac tcggcaaaaa agtctttgcc atgtgccgca ctcggcaaag   1560tcctgctctc ggtaacgacc gcgtttaccg agagcaggac tctcgacaca gaaatacact   1620cgacaaagaa atctttgccg agagccaaac actcggcgaa cggcagcgct cggcaaaggg   1680tcgtcagccg ccgtctaaag ctgacggtcg ttatctttgt cgagtgcccc ctcgtccgac   1740actcagtaga gcacgcgccg gtatgaattt ggaaacaaat tcagtacttt taaaaaaatt   1800tgttgtaggg agcaaataat acataaaata atttatgcat tattttattt tttatttgta   1860ataatatgct tgaaacgata attcagtatg catgttgtgc cagtgtacta cacgggcggg   1920gggaggggat tgagtgggcc agcgcggtgc gtagggtaga tgggctgaaa ttgataactc   1980aagtccgact aggttctctt tttatttccc ttccttttct attttccttt cttttaattt   2040tcatgctttc aaactaaatt caaattcgag ttttgaattt cagcttctaa attgtacact   2100aaaattatat gataaggtaa cccctactat tacttttaat ttttttattc taccccatat   2160tgtttactta ggggagaata attgacttaa tcacattctt cctaggtttc aattctcaat   2220ctttcaaatc cacattttta gatttctatt ttgaatttaa ataccagttt ggatttagag   2280ttcaatttca aaatacacaa ccaaaatacc agcatgaatg caaatatatt ttatgtttat   2340gtatttactt ttcttttata ctttgctcaa aatagttatt ttcatgtatg aaactcaata   2400agcaaggaac tcacgttatt atataaccta ataggaataa tttaggtaac ataatttatc   2460atcctcttga tttaaaagag atatgcctcc agaataagac acatactaaa aataactcta   2520atattgaata actaaagtcg tacaaatctc tactattatt cctataaaat aataaagaac   2580tagctacaac ttctttaagg cattattcag ggtttacagc ttgagaggca tgaacccatc   2640ctgtatactc ctggacttgg aagacaaaat gtcaaccaaa gtgaaaggtt ttcttatggt   2700tgctgctaag agatagattg aacactagat ctctcctaag acgtcagggc atgcgtttag   2760actcctacac atgcgaaaac tgcatcttac agttggaaga aactatatct caccacttcc   2820tgcggtgtaa ctttgcccaa agatgttggc tcactgttgg aatcactccg ccccgaactt   2880tggatctaac gcttgcagtg ctacatatta gagcaagact aacaatgccg tggagaatgg   2940aaggtattat aaccatgtca tggtgcatat ggaaatgtcg aaataactgg atattcgaaa   3000acataccgcc aacggtggcg gcctgcaagg aaatgttcaa gactgaaatg aactacatct   3060gctaccaagt taagctcgag acaggagcta aaagtagaaa ctggatacaa cactttgtaa   3120catagtgaca ctcccctttt cctttctttt accttagaac tatacataca atccacattc   3180aataaaaatt tgtaggtacg ccatacacac taccggaatc cggctctttg ccgagtgtga   3240ggcgctttgt cgagtgcttt ttgtccagca ctcggcaaaa aagtctttgc catgtgccgc   3300actcggcaaa gtcctgctct cggtaacgac cgcgtttacc gagagcagga ctctcgacac   3360agaaatacac tcgacaaaga aatctttgcc gagagccaaa cactcggcga acggcagcgc   3420tcggcaaagg gtcgtcagcc gccgtctaaa gctgacggtc gttatctttg tcgagtgccc   3480cctcgtccga cactcagtag agcacgcgcc ggtatgaatt tggaaacaaa ttcagtactt   3540ttaaaaaaat ttgttgtagg gagcaaataa tacataaaat aatttatgca ttattttatt   3600ttttatttgt aataatatgc ttgaaacgat aattcagtat gcatgttgtg ccagtgtact   3660acacgggcgg ggggagggga ttgagtgggc cagcgcggtg cgtagggtag atgggctgaa   3720attgataact caagtccgac taggttctct ttttatttcc cttccttttc tattttcctt   3780tcttttaatt ttcatgcttt caaactaaat tcaaattcga gttttgaatt tcagcttcta   3840aattgtacac taaaattata tgataaggta acccctacta ttacttttaa tttttttatt   3900ctaccccata ttgtttactt aggggagaat aattgactta atcacattct tcctaggttt   3960caattctcaa tctttcaaat ccacattttt agatttctat tttgaattta aataccagtt   4020tggatttaga gttcaatttc aaaatacaca accaaaatac cagcatgaat gcaaatatat   4080tttatgttta tgtatttact tttcttttat actttgctca aaatagttat tttcatgtat   4140gaaactcaat aagcaaggaa ctcacgttat tatataacct aataggaata atttaggtaa   4200cataatttat catcctcttg atttaaaaga gatatgcctc cagaataaga cacatactaa   4260aaataactct aatattgaat aactaaagtc gtacaaatct ctactattat tcctataaaa   4320taataaagaa ctagctacaa cttctttaag gcattattca gggtttacag cttgagaggc   4380atgaacccat cctgtatact cctggacttg gaagacaaaa tgtcaaccaa agtgaaaggt   4440tttcttatgg ttgctgctaa gagatagatt gaacactaga tctctcctaa gacgtcaggg   4500catgcgttta gactcctaca catgcgaaaa ctgcatctta cagttggaag aaactatatc   4560tcaccacttc ctgcggtgta actttgccca aagatgttgg ctcactgttg gaatcactcc   4620gccccgaact ttggatctaa cgcttgcagt gctacatatt agagcaagac taacaatgcc   4680gtggagaatg gaaggtatta taaccatgtc atggtgcata tggaaatgtc gaaataactg   4740gatattcgaa aacataccgc caacggtggc ggcctgcaag gaaatgttca agactgaaat   4800gaactacatc tgctaccaag ttaagctcga gacaggagct aaaagtagaa actggataca   4860acactttgta acatagtgac actccccttt tcctttcttt taccttagaa ctatacatac   4920aatccacatt caataaaaat ttgtaggtac gccatacaca ctaccggaat ccggctcttt   4980gccgagtgtg aggcgctttg tcgagtgctt tttgtccagc actcggcaaa aaagtctttg   5040ccatgtgccg cactcggcaa agtcctgctc tcggtaacga ccgcgtttac cgagagcagg   5100actctcgaca cagaaataca ctcgacaaag aaatctttgc cgagagccaa acactcggcg   5160aacggcagcg ctcggcaaag ggtcgtcagc cgccgtctaa agctgacggt cgttatcttt   5220gtcgagtgcc ccctcgtccg acactcagta gagcaagctt gccgagtgcc atccttggac   5280actcgataaa gtatatttta ttttttttta ttttgccaac caaacttttt gtggtatgtt   5340cctacactat gtagatctac atgtaccatt ttggcacaat tacaaaaatg ttttctataa   5400ctattagatt tagttcgttt atttgaattt cttcggaaaa ttcacatatg aactgcaagt   5460cactcgaaac atgaaaaacc gtgcatgcaa aataaatgat atgcatgtta tctagcacaa   5520gttacgaccg aattcagaag cagaccagaa tcttcaagca ccatgctcac taaacatgac   5580cgtgaacttg ttatccagtt gtttaaaaat tgtataaaac acaaataaag tcagaaatta   5640atgaaacttg tccacatgtc atgatatcat atatagaggt tgtgataaaa atttgataat   5700gtttcggtaa agttgtgacg tactatgtgt agaaacctaa gtgacctaca cataaaatca   5760tagagtttca atgtagttca ctcgacaaag actttgtcaa gtgtccgata aaaagtattc   5820agcaaagaag ccgttgtcga tttactgttc gtcgagatct ctttgccgag tgtcacacta   5880ggcaaagtct ttacggagtg tttttcaggc tttgacactc ggcaaagcgc tcgattccag   5940tagtgacagt aatttgcatc aaaaatagcc gagagattta aaatgagtca actaatagac   6000caactaatta ttagctatta gtcgttagct tctttaatct aagctaaaac caactaatag   6060cttatttgtt gaattacaat tagctcaacg gaattctctg ttttttctat aaaaaaaagg   6120gaaactgccc ctcatttaca gcaaactgtc cgctgcctgt cgtccagata caatgaacgt   6180acctagtagg aactctttta cacgctcggt cgctcgccgc ggatcggagt cccaggaaca   6240cgacaccact gtggaacacg acaaagtctg ctcagaggcg gccacaccct ggcgtgcacc   6300gagccggagc ccggataagc acggtaagga gagtacggcg ggacgtggcg acccgtgtgt   6360ctgctgccac gcagccttcc tccacgtagc cgcgcggccg cgccacgtac cagggcccgg   6420cgctggtata aatgcgcgcc acctccgctt tagttctgca tacagccaac ccaacacaca   6480cccgagcata tcacagtgac agacactaca                                    6510</s400><s200><s210>13</s210><s211>12</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 13aaggacgagc tc                                                         12</s400><s200><s210>14</s210><s211>4</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 14His Asp Glu Leu1</s400><s200><s210>15</s210><s211>2217</s211><s212>DNA</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 15atggcgaaca agcacctgag ccttagcctc ttcctcgtgc tcctgggcct ctccgcctcc     60ctcgcctccg gcgtcactcg ctgccagtcg accatcaact tccgcaggtt cttctccaag    120ttcaacgtgc aggcccccgc ggtggtggtg ctcggcggct acctgccctc catgaattct    180agctcctggt actgcggcac gggcatcgag acggactcgg gcgtgcacgg catcttcctc    240agctacatcg actccggcca gggcttcgag atcggcatct cgcaggagcc cttcgaccca    300tcgggctacc agctctacct gcacaaggcc accaacggca acacgaacgc gatcgcccgc    360ctcaggatct gccagttccc ggacaacaag accctgggcc caaccgtcaa cgacgtgacc    420accggccgca actgcctgtt caacaaggcg atcccggcct acctccagga cggcaagaac    480atcgtcgtgg gcatcacgtg ggacaacgac agggtcaccg tgttcgcgga caagatctac    540cacttctacc tcaagaacga ctggtcccgc gtcgcgacca ggtgctacaa caagcgcagc    600tgcgccatgc agtatgtgta caccccgacg tactacatgc tcaacgtgac ctcggcgggc    660gaggacggca tctactacga gccgtgcacg gccaactgct cgggctacgc ggccaacgtg    720ttcgctaccg actccaacgg ccacatcccg gagggcttca gcttcaacaa ctggttcctc    780ctgagcaacg actccaccct cctgcacggc aaggtcgtgt ccaaccagcc gctcctggtc    840aactgcctcc tggcgatccc caagatctac ggcctgggcc agttcttcag cttcaaccag    900acgatggacg gcgtgtgcaa cggcgcggcc gctcagaggg cccccgaggc cctcaggttc    960aacatcaacg acacgagcgt catcctggcc gagggctcca tcgtgctcca cacggctctg   1020ggcacgaacc tcagcttcgt gtgctccaac agctccgacc cccacctggc catcttcgct   1080atccccctgg gcgccacgga ggtcccctac tactgcttcc tgaaggtgga cacctacaac   1140agcacggtct acaagttcct ggcggtgctg ccgcccacgg tcagggagat cgtgatcacc   1200aagtacggcg acgtctacgt gaacggcttc ggctacctcc acctgggcct cctggacgcg   1260gtcaccatca acttcaccgg ccacggcacg gacgacgacg tgagcggctt ctggacgatc   1320gcgagcacca acttcgtgga cgctctcatc gaggtgcagg gcaccgcgat ccagaggatc   1380ctgtactgcg acgacccggt cagccagctc aagtgctccc aggtggcctt cgacctggac   1440gacggcttct accccatcag ctcccgcaac ctcctgagcc acgagcagcc gatctccttc   1500gtcaccctgc ccagcttcaa cgaccactcc ttcgtcaaca tcacggtgag cgccgctttc   1560ggtggccact cgggcgccaa cctcatcgct tccgacacca cgatcaacgg cttcagctcc   1620ttctgcgtgg acacgcgcca gttcaccatc acgctgttct acaacgtcac caactcctac   1680ggctacgtga gcaagtccca ggactccaac tgcccgttca ccctgcagag cgtcaacgac   1740tacctcagct tctccaagtt ctgcgtgagc acgtccctcc tggccggcgc ttgcaccatc   1800gacctcttcg gctaccccga gttcggcagc ggcgtcaagt tcacgtccct gtacttccag   1860ttcaccaagg gcgagctgat cacgggcacc cccaagccac tggagggcgt cacggacgtg   1920agcttcatga ccctcgacgt gtgcaccaag tacacgatct acggcttcaa gggcgagggc   1980atcatcaccc tgacgaactc aagctttctc gccggcgtct actacaccag cgactccggc   2040cagctcctgg cgttcaagaa cgtgacctcg ggcgcggtct actcggtgac gccctgcagc   2100ttctccgagc aggccgccta cgtggacgac gacatcgtcg gcgtgatcag ctccctgagc   2160aactcaacat tcaacaacac tcgggagctg cctggcttct tctaccattc ctgatag      2217</s400><s200><s210>16</s210><s211>1273</s211><s212>PRT</s212><s213>Severe acute respiratory syndrome coronavirus 2</s213></s200><s400> 16Met Phe Val Phe Leu Val Leu Leu Pro Leu Val Ser Ser Gln Cys Val1               5                   10                  15Asn Leu Thr Thr Arg Thr Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe            20                  25                  30Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe Arg Ser Ser Val Leu        35                  40                  45His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe Ser Asn Val Thr Trp    50                  55                  60Phe His Ala Ile His Val Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp65                  70                  75                  80Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu                85                  90                  95Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser            100                 105                 110Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala Thr Asn Val Val Ile        115                 120                 125Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr    130                 135                 140Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser Glu Phe Arg Val Tyr145                 150                 155                 160Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu                165                 170                 175Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe            180                 185                 190Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr        195                 200                 205Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu    210                 215                 220Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr225                 230                 235                 240Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser                245                 250                 255Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro            260                 265                 270Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala        275                 280                 285Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys    290                 295                 300Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val305                 310                 315                 320Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr Asn Leu Cys                325                 330                 335Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala            340                 345                 350Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr Ser Val Leu        355                 360                 365Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro    370                 375                 380Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe385                 390                 395                 400Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly                405                 410                 415Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys            420                 425                 430Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn        435                 440                 445Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe    450                 455                 460Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys465                 470                 475                 480Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly                485                 490                 495Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val            500                 505                 510Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys Gly Pro Lys        515                 520                 525Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe Asn Phe Asn    530                 535                 540Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu545                 550                 555                 560Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val                565                 570                 575Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe            580                 585                 590Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn Thr Ser Asn Gln Val        595                 600                 605Ala Val Leu Tyr Gln Asp Val Asn Cys Thr Glu Val Pro Val Ala Ile    610                 615                 620His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser625                 630                 635                 640Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile Gly Ala Glu His Val                645                 650                 655Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala            660                 665                 670Ser Tyr Gln Thr Gln Thr Asn Ser Pro Arg Arg Ala Arg Ser Val Ala        675                 680                 685Ser Gln Ser Ile Ile Ala Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser    690                 695                 700Val Ala Tyr Ser Asn Asn Ser Ile Ala Ile Pro Thr Asn Phe Thr Ile705                 710                 715                 720Ser Val Thr Thr Glu Ile Leu Pro Val Ser Met Thr Lys Thr Ser Val                725                 730                 735Asp Cys Thr Met Tyr Ile Cys Gly Asp Ser Thr Glu Cys Ser Asn Leu            740                 745                 750Leu Leu Gln Tyr Gly Ser Phe Cys Thr Gln Leu Asn Arg Ala Leu Thr        755                 760                 765Gly Ile Ala Val Glu Gln Asp Lys Asn Thr Gln Glu Val Phe Ala Gln    770                 775                 780Val Lys Gln Ile Tyr Lys Thr Pro Pro Ile Lys Asp Phe Gly Gly Phe785                 790                 795                 800Asn Phe Ser Gln Ile Leu Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser                805                 810                 815Phe Ile Glu Asp Leu Leu Phe Asn Lys Val Thr Leu Ala Asp Ala Gly            820                 825                 830Phe Ile Lys Gln Tyr Gly Asp Cys Leu Gly Asp Ile Ala Ala Arg Asp        835                 840                 845Leu Ile Cys Ala Gln Lys Phe Asn Gly Leu Thr Val Leu Pro Pro Leu    850                 855                 860Leu Thr Asp Glu Met Ile Ala Gln Tyr Thr Ser Ala Leu Leu Ala Gly865                 870                 875                 880Thr Ile Thr Ser Gly Trp Thr Phe Gly Ala Gly Ala Ala Leu Gln Ile                885                 890                 895Pro Phe Ala Met Gln Met Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr            900                 905                 910Gln Asn Val Leu Tyr Glu Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn        915                 920                 925Ser Ala Ile Gly Lys Ile Gln Asp Ser Leu Ser Ser Thr Ala Ser Ala    930                 935                 940Leu Gly Lys Leu Gln Asp Val Val Asn Gln Asn Ala Gln Ala Leu Asn945                 950                 955                 960Thr Leu Val Lys Gln Leu Ser Ser Asn Phe Gly Ala Ile Ser Ser Val                965                 970                 975Leu Asn Asp Ile Leu Ser Arg Leu Asp Lys Val Glu Ala Glu Val Gln            980                 985                 990Ile Asp Arg Leu Ile Thr Gly Arg  Leu Gln Ser Leu Gln  Thr Tyr Val        995                 1000                 1005Thr Gln  Gln Leu Ile Arg Ala  Ala Glu Ile Arg Ala  Ser Ala Asn    1010                 1015                 1020Leu Ala  Ala Thr Lys Met Ser  Glu Cys Val Leu Gly  Gln Ser Lys    1025                 1030                 1035Arg Val  Asp Phe Cys Gly Lys  Gly Tyr His Leu Met  Ser Phe Pro    1040                 1045                 1050Gln Ser  Ala Pro His Gly Val  Val Phe Leu His Val  Thr Tyr Val    1055                 1060                 1065Pro Ala  Gln Glu Lys Asn Phe  Thr Thr Ala Pro Ala  Ile Cys His    1070                 1075                 1080Asp Gly  Lys Ala His Phe Pro  Arg Glu Gly Val Phe  Val Ser Asn    1085                 1090                 1095Gly Thr  His Trp Phe Val Thr  Gln Arg Asn Phe Tyr  Glu Pro Gln    1100                 1105                 1110Ile Ile  Thr Thr Asp Asn Thr  Phe Val Ser Gly Asn  Cys Asp Val    1115                 1120                 1125Val Ile  Gly Ile Val Asn Asn  Thr Val Tyr Asp Pro  Leu Gln Pro    1130                 1135                 1140Glu Leu  Asp Ser Phe Lys Glu  Glu Leu Asp Lys Tyr  Phe Lys Asn    1145                 1150                 1155His Thr  Ser Pro Asp Val Asp  Leu Gly Asp Ile Ser  Gly Ile Asn    1160                 1165                 1170Ala Ser  Val Val Asn Ile Gln  Lys Glu Ile Asp Arg  Leu Asn Glu    1175                 1180                 1185Val Ala  Lys Asn Leu Asn Glu  Ser Leu Ile Asp Leu  Gln Glu Leu    1190                 1195                 1200Gly Lys  Tyr Glu Gln Tyr Ile  Lys Trp Pro Trp Tyr  Ile Trp Leu    1205                 1210                 1215Gly Phe  Ile Ala Gly Leu Ile  Ala Ile Val Met Val  Thr Ile Met    1220                 1225                 1230Leu Cys  Cys Met Thr Ser Cys  Cys Ser Cys Leu Lys  Gly Cys Cys    1235                 1240                 1245Ser Cys  Gly Ser Cys Cys Lys  Phe Asp Glu Asp Asp  Ser Glu Pro    1250                 1255                 1260Val Leu  Lys Gly Val Lys Leu  His Tyr Thr    1265                 1270</s400><s200><s210>17</s210><s211>687</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 17Met Ala Asn Lys His Leu Ser Leu Ser Leu Phe Leu Val Leu Leu Gly1               5                   10                  15Leu Ser Ala Ser Leu Ala Ser Gly Val Gln Leu Pro Pro Ala Tyr Thr            20                  25                  30Asn Ser Phe Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe Arg Ser        35                  40                  45Ser Val Leu His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe Ser Asn    50                  55                  60Val Thr Trp Phe His Ala Ile His Val Ser Gly Thr Asn Gly Thr Lys65                  70                  75                  80Arg Phe Asp Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr Phe Ala                85                  90                  95Ser Thr Glu Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly Thr Thr            100                 105                 110Leu Asp Ser Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala Thr Asn        115                 120                 125Val Val Ile Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro Phe Leu    130                 135                 140Gly Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser Glu Phe145                 150                 155                 160Arg Val Tyr Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val Ser Gln                165                 170                 175Pro Phe Leu Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys Asn Leu            180                 185                 190Arg Glu Phe Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile Tyr Ser        195                 200                 205Lys His Thr Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly Phe Ser    210                 215                 220Ala Leu Glu Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile Thr Arg225                 230                 235                 240Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro Gly Asp                245                 250                 255Ser Ser Ser Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val Gly Tyr            260                 265                 270Leu Gln Pro Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly Thr Ile        275                 280                 285Thr Asp Ala Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr Lys Cys    290                 295                 300Thr Leu Lys Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn305                 310                 315                 320Phe Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr                325                 330                 335Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser            340                 345                 350Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr        355                 360                 365Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly    370                 375                 380Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala385                 390                 395                 400Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly                405                 410                 415Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe            420                 425                 430Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val        435                 440                 445Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu    450                 455                 460Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser465                 470                 475                 480Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln                485                 490                 495Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg            500                 505                 510Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys        515                 520                 525Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe    530                 535                 540Asn Phe Asn Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser Asn Lys545                 550                 555                 560Lys Phe Leu Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr                565                 570                 575Asp Ala Val Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile Thr Pro            580                 585                 590Cys Ser Phe Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn Thr Ser        595                 600                 605Asn Gln Val Ala Val Leu Tyr Gln Asp Val Asn Cys Thr Glu Val Pro    610                 615                 620Val Ala Ile His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr Ser625                 630                 635                 640Thr Gly Ser Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile Gly Ala                645                 650                 655Glu His Val Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly            660                 665                 670Ile Cys Ala Ser Tyr Gln Thr Gln Thr Asn Ser Pro Arg Arg Ala        675                 680                 685</s400><s200><s210>18</s210><s211>691</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 18Met Ala Asn Lys His Leu Ser Leu Ser Leu Phe Leu Val Leu Leu Gly1               5                   10                  15Leu Ser Ala Ser Leu Ala Ser Gly Val Gln Leu Pro Pro Ala Tyr Thr            20                  25                  30Asn Ser Phe Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe Arg Ser        35                  40                  45Ser Val Leu His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe Ser Asn    50                  55                  60Val Thr Trp Phe His Ala Ile His Val Ser Gly Thr Asn Gly Thr Lys65                  70                  75                  80Arg Phe Asp Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr Phe Ala                85                  90                  95Ser Thr Glu Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly Thr Thr            100                 105                 110Leu Asp Ser Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala Thr Asn        115                 120                 125Val Val Ile Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro Phe Leu    130                 135                 140Gly Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser Glu Phe145                 150                 155                 160Arg Val Tyr Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val Ser Gln                165                 170                 175Pro Phe Leu Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys Asn Leu            180                 185                 190Arg Glu Phe Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile Tyr Ser        195                 200                 205Lys His Thr Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly Phe Ser    210                 215                 220Ala Leu Glu Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile Thr Arg225                 230                 235                 240Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro Gly Asp                245                 250                 255Ser Ser Ser Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val Gly Tyr            260                 265                 270Leu Gln Pro Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly Thr Ile        275                 280                 285Thr Asp Ala Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr Lys Cys    290                 295                 300Thr Leu Lys Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn305                 310                 315                 320Phe Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr                325                 330                 335Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser            340                 345                 350Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr        355                 360                 365Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly    370                 375                 380Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala385                 390                 395                 400Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly                405                 410                 415Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe            420                 425                 430Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val        435                 440                 445Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu    450                 455                 460Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser465                 470                 475                 480Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln                485                 490                 495Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg            500                 505                 510Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys        515                 520                 525Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe    530                 535                 540Asn Phe Asn Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser Asn Lys545                 550                 555                 560Lys Phe Leu Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr                565                 570                 575Asp Ala Val Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile Thr Pro            580                 585                 590Cys Ser Phe Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn Thr Ser        595                 600                 605Asn Gln Val Ala Val Leu Tyr Gln Asp Val Asn Cys Thr Glu Val Pro    610                 615                 620Val Ala Ile His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr Ser625                 630                 635                 640Thr Gly Ser Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile Gly Ala                645                 650                 655Glu His Val Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly            660                 665                 670Ile Cys Ala Ser Tyr Gln Thr Gln Thr Asn Ser Pro Arg Arg Ala Lys        675                 680                 685Asp Glu Leu    690</s400><s200><s210>19</s210><s211>699</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 19Met Ala Asn Lys His Leu Ser Leu Ser Leu Phe Leu Val Leu Leu Gly1               5                   10                  15Leu Ser Ala Ser Leu Ala Ser Gly Val Gln Leu Pro Pro Ala Tyr Thr            20                  25                  30Asn Ser Phe Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe Arg Ser        35                  40                  45Ser Val Leu His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe Ser Asn    50                  55                  60Val Thr Trp Phe His Ala Ile His Val Ser Gly Thr Asn Gly Thr Lys65                  70                  75                  80Arg Phe Asp Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr Phe Ala                85                  90                  95Ser Thr Glu Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly Thr Thr            100                 105                 110Leu Asp Ser Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala Thr Asn        115                 120                 125Val Val Ile Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro Phe Leu    130                 135                 140Gly Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser Glu Phe145                 150                 155                 160Arg Val Tyr Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val Ser Gln                165                 170                 175Pro Phe Leu Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys Asn Leu            180                 185                 190Arg Glu Phe Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile Tyr Ser        195                 200                 205Lys His Thr Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly Phe Ser    210                 215                 220Ala Leu Glu Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile Thr Arg225                 230                 235                 240Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro Gly Asp                245                 250                 255Ser Ser Ser Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val Gly Tyr            260                 265                 270Leu Gln Pro Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly Thr Ile        275                 280                 285Thr Asp Ala Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr Lys Cys    290                 295                 300Thr Leu Lys Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn305                 310                 315                 320Phe Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr                325                 330                 335Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser            340                 345                 350Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr        355                 360                 365Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly    370                 375                 380Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala385                 390                 395                 400Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly                405                 410                 415Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe            420                 425                 430Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val        435                 440                 445Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu    450                 455                 460Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser465                 470                 475                 480Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln                485                 490                 495Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg            500                 505                 510Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys        515                 520                 525Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe    530                 535                 540Asn Phe Asn Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser Asn Lys545                 550                 555                 560Lys Phe Leu Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr                565                 570                 575Asp Ala Val Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile Thr Pro            580                 585                 590Cys Ser Phe Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn Thr Ser        595                 600                 605Asn Gln Val Ala Val Leu Tyr Gln Asp Val Asn Cys Thr Glu Val Pro    610                 615                 620Val Ala Ile His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr Ser625                 630                 635                 640Thr Gly Ser Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile Gly Ala                645                 650                 655Glu His Val Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly            660                 665                 670Ile Cys Ala Ser Tyr Gln Thr Gln Thr Asn Ser Pro Arg Arg Ala Phe        675                 680                 685Tyr Pro Ser Tyr His Ser Thr Pro Gln Arg Pro    690                 695</s400><s200><s210>20</s210><s211>790</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 20Met Ala Asn Lys His Leu Ser Leu Ser Leu Phe Leu Val Leu Leu Gly1               5                   10                  15Leu Ser Ala Ser Leu Ala Ser Gly Val Gln Leu Pro Pro Ala Tyr Thr            20                  25                  30Asn Ser Phe Thr Arg Gly Val Tyr Tyr Pro Asp Lys Val Phe Arg Ser        35                  40                  45Ser Val Leu His Ser Thr Gln Asp Leu Phe Leu Pro Phe Phe Ser Asn    50                  55                  60Val Thr Trp Phe His Ala Ile His Val Ser Gly Thr Asn Gly Thr Lys65                  70                  75                  80Arg Phe Asp Asn Pro Val Leu Pro Phe Asn Asp Gly Val Tyr Phe Ala                85                  90                  95Ser Thr Glu Lys Ser Asn Ile Ile Arg Gly Trp Ile Phe Gly Thr Thr            100                 105                 110Leu Asp Ser Lys Thr Gln Ser Leu Leu Ile Val Asn Asn Ala Thr Asn        115                 120                 125Val Val Ile Lys Val Cys Glu Phe Gln Phe Cys Asn Asp Pro Phe Leu    130                 135                 140Gly Val Tyr Tyr His Lys Asn Asn Lys Ser Trp Met Glu Ser Glu Phe145                 150                 155                 160Arg Val Tyr Ser Ser Ala Asn Asn Cys Thr Phe Glu Tyr Val Ser Gln                165                 170                 175Pro Phe Leu Met Asp Leu Glu Gly Lys Gln Gly Asn Phe Lys Asn Leu            180                 185                 190Arg Glu Phe Val Phe Lys Asn Ile Asp Gly Tyr Phe Lys Ile Tyr Ser        195                 200                 205Lys His Thr Pro Ile Asn Leu Val Arg Asp Leu Pro Gln Gly Phe Ser    210                 215                 220Ala Leu Glu Pro Leu Val Asp Leu Pro Ile Gly Ile Asn Ile Thr Arg225                 230                 235                 240Phe Gln Thr Leu Leu Ala Leu His Arg Ser Tyr Leu Thr Pro Gly Asp                245                 250                 255Ser Ser Ser Gly Trp Thr Ala Gly Ala Ala Ala Tyr Tyr Val Gly Tyr            260                 265                 270Leu Gln Pro Arg Thr Phe Leu Leu Lys Tyr Asn Glu Asn Gly Thr Ile        275                 280                 285Thr Asp Ala Val Asp Cys Ala Leu Asp Pro Leu Ser Glu Thr Lys Cys    290                 295                 300Thr Leu Lys Ser Phe Thr Val Glu Lys Gly Ile Tyr Gln Thr Ser Asn305                 310                 315                 320Phe Arg Val Gln Pro Thr Glu Ser Ile Val Arg Phe Pro Asn Ile Thr                325                 330                 335Asn Leu Cys Pro Phe Gly Glu Val Phe Asn Ala Thr Arg Phe Ala Ser            340                 345                 350Val Tyr Ala Trp Asn Arg Lys Arg Ile Ser Asn Cys Val Ala Asp Tyr        355                 360                 365Ser Val Leu Tyr Asn Ser Ala Ser Phe Ser Thr Phe Lys Cys Tyr Gly    370                 375                 380Val Ser Pro Thr Lys Leu Asn Asp Leu Cys Phe Thr Asn Val Tyr Ala385                 390                 395                 400Asp Ser Phe Val Ile Arg Gly Asp Glu Val Arg Gln Ile Ala Pro Gly                405                 410                 415Gln Thr Gly Lys Ile Ala Asp Tyr Asn Tyr Lys Leu Pro Asp Asp Phe            420                 425                 430Thr Gly Cys Val Ile Ala Trp Asn Ser Asn Asn Leu Asp Ser Lys Val        435                 440                 445Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg Leu Phe Arg Lys Ser Asn Leu    450                 455                 460Lys Pro Phe Glu Arg Asp Ile Ser Thr Glu Ile Tyr Gln Ala Gly Ser465                 470                 475                 480Thr Pro Cys Asn Gly Val Glu Gly Phe Asn Cys Tyr Phe Pro Leu Gln                485                 490                 495Ser Tyr Gly Phe Gln Pro Thr Asn Gly Val Gly Tyr Gln Pro Tyr Arg            500                 505                 510Val Val Val Leu Ser Phe Glu Leu Leu His Ala Pro Ala Thr Val Cys        515                 520                 525Gly Pro Lys Lys Ser Thr Asn Leu Val Lys Asn Lys Cys Val Asn Phe    530                 535                 540Asn Phe Asn Gly Leu Thr Gly Thr Gly Val Leu Thr Glu Ser Asn Lys545                 550                 555                 560Lys Phe Leu Pro Phe Gln Gln Phe Gly Arg Asp Ile Ala Asp Thr Thr                565                 570                 575Asp Ala Val Arg Asp Pro Gln Thr Leu Glu Ile Leu Asp Ile Thr Pro            580                 585                 590Cys Ser Phe Gly Gly Val Ser Val Ile Thr Pro Gly Thr Asn Thr Ser        595                 600                 605Asn Gln Val Ala Val Leu Tyr Gln Asp Val Asn Cys Thr Glu Val Pro    610                 615                 620Val Ala Ile His Ala Asp Gln Leu Thr Pro Thr Trp Arg Val Tyr Ser625                 630                 635                 640Thr Gly Ser Asn Val Phe Gln Thr Arg Ala Gly Cys Leu Ile Gly Ala                645                 650                 655Glu His Val Asn Asn Ser Tyr Glu Cys Asp Ile Pro Ile Gly Ala Gly            660                 665                 670Ile Cys Ala Ser Tyr Gln Thr Gln Thr Asn Ser Pro Arg Arg Ala Ala        675                 680                 685Pro Gln Ser Ile Thr Glu Leu Cys Ser Glu Tyr His Asn Thr Gln Ile    690                 695                 700Tyr Thr Ile Asn Asp Lys Ile Leu Ser Tyr Thr Glu Ser Met Ala Gly705                 710                 715                 720Lys Arg Glu Met Val Ile Ile Thr Phe Lys Ser Gly Ala Thr Phe Gln                725                 730                 735Val Glu Val Pro Gly Ser Gln His Ile Asp Ser Gln Lys Lys Ala Ile            740                 745                 750Glu Arg Met Lys Asp Thr Leu Arg Ile Thr Tyr Leu Thr Glu Thr Lys        755                 760                 765Ile Asp Lys Leu Cys Val Trp Asn Asn Lys Thr Pro Asn Ser Ile Ala    770                 775                 780Ala Ile Ser Met Glu Asn785                 790</s400><s200><s210>21</s210><s211>663</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 21Val Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr1               5                   10                  15Tyr Pro Asp Lys Val Phe Arg Ser Ser Val Leu His Ser Thr Gln Asp            20                  25                  30Leu Phe Leu Pro Phe Phe Ser Asn Val Thr Trp Phe His Ala Ile His        35                  40                  45Val Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp Asn Pro Val Leu Pro    50                  55                  60Phe Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile65                  70                  75                  80Arg Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu                85                  90                  95Leu Ile Val Asn Asn Ala Thr Asn Val Val Ile Lys Val Cys Glu Phe            100                 105                 110Gln Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr Tyr His Lys Asn Asn        115                 120                 125Lys Ser Trp Met Glu Ser Glu Phe Arg Val Tyr Ser Ser Ala Asn Asn    130                 135                 140Cys Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu Met Asp Leu Glu Gly145                 150                 155                 160Lys Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe Val Phe Lys Asn Ile                165                 170                 175Asp Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr Pro Ile Asn Leu Val            180                 185                 190Arg Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu Pro Leu Val Asp Leu        195                 200                 205Pro Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His    210                 215                 220Arg Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser Gly Trp Thr Ala Gly225                 230                 235                 240Ala Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu                245                 250                 255Lys Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala Val Asp Cys Ala Leu            260                 265                 270Asp Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys Ser Phe Thr Val Glu        275                 280                 285Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val Gln Pro Thr Glu Ser    290                 295                 300Ile Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val305                 310                 315                 320Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg                325                 330                 335Ile Ser Asn Cys Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser            340                 345                 350Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp        355                 360                 365Leu Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp    370                 375                 380Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr385                 390                 395                 400Asn Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys Val Ile Ala Trp Asn                405                 410                 415Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr            420                 425                 430Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser        435                 440                 445Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu Gly    450                 455                 460Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn465                 470                 475                 480Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe Glu Leu                485                 490                 495Leu His Ala Pro Ala Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu            500                 505                 510Val Lys Asn Lys Cys Val Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr        515                 520                 525Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe    530                 535                 540Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp Pro Gln Thr545                 550                 555                 560Leu Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe Gly Gly Val Ser Val                565                 570                 575Ile Thr Pro Gly Thr Asn Thr Ser Asn Gln Val Ala Val Leu Tyr Gln            580                 585                 590Asp Val Asn Cys Thr Glu Val Pro Val Ala Ile His Ala Asp Gln Leu        595                 600                 605Thr Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser Asn Val Phe Gln Thr    610                 615                 620Arg Ala Gly Cys Leu Ile Gly Ala Glu His Val Asn Asn Ser Tyr Glu625                 630                 635                 640Cys Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr Gln Thr Gln                645                 650                 655Thr Asn Ser Pro Arg Arg Ala            660</s400><s200><s210>22</s210><s211>667</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 22Val Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr1               5                   10                  15Tyr Pro Asp Lys Val Phe Arg Ser Ser Val Leu His Ser Thr Gln Asp            20                  25                  30Leu Phe Leu Pro Phe Phe Ser Asn Val Thr Trp Phe His Ala Ile His        35                  40                  45Val Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp Asn Pro Val Leu Pro    50                  55                  60Phe Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile65                  70                  75                  80Arg Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu                85                  90                  95Leu Ile Val Asn Asn Ala Thr Asn Val Val Ile Lys Val Cys Glu Phe            100                 105                 110Gln Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr Tyr His Lys Asn Asn        115                 120                 125Lys Ser Trp Met Glu Ser Glu Phe Arg Val Tyr Ser Ser Ala Asn Asn    130                 135                 140Cys Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu Met Asp Leu Glu Gly145                 150                 155                 160Lys Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe Val Phe Lys Asn Ile                165                 170                 175Asp Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr Pro Ile Asn Leu Val            180                 185                 190Arg Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu Pro Leu Val Asp Leu        195                 200                 205Pro Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His    210                 215                 220Arg Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser Gly Trp Thr Ala Gly225                 230                 235                 240Ala Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu                245                 250                 255Lys Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala Val Asp Cys Ala Leu            260                 265                 270Asp Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys Ser Phe Thr Val Glu        275                 280                 285Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val Gln Pro Thr Glu Ser    290                 295                 300Ile Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val305                 310                 315                 320Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg                325                 330                 335Ile Ser Asn Cys Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser            340                 345                 350Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp        355                 360                 365Leu Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp    370                 375                 380Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr385                 390                 395                 400Asn Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys Val Ile Ala Trp Asn                405                 410                 415Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr            420                 425                 430Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser        435                 440                 445Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu Gly    450                 455                 460Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn465                 470                 475                 480Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe Glu Leu                485                 490                 495Leu His Ala Pro Ala Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu            500                 505                 510Val Lys Asn Lys Cys Val Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr        515                 520                 525Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe    530                 535                 540Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp Pro Gln Thr545                 550                 555                 560Leu Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe Gly Gly Val Ser Val                565                 570                 575Ile Thr Pro Gly Thr Asn Thr Ser Asn Gln Val Ala Val Leu Tyr Gln            580                 585                 590Asp Val Asn Cys Thr Glu Val Pro Val Ala Ile His Ala Asp Gln Leu        595                 600                 605Thr Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser Asn Val Phe Gln Thr    610                 615                 620Arg Ala Gly Cys Leu Ile Gly Ala Glu His Val Asn Asn Ser Tyr Glu625                 630                 635                 640Cys Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr Gln Thr Gln                645                 650                 655Thr Asn Ser Pro Arg Arg Ala Lys Asp Glu Leu            660                 665</s400><s200><s210>23</s210><s211>675</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 23Val Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr1               5                   10                  15Tyr Pro Asp Lys Val Phe Arg Ser Ser Val Leu His Ser Thr Gln Asp            20                  25                  30Leu Phe Leu Pro Phe Phe Ser Asn Val Thr Trp Phe His Ala Ile His        35                  40                  45Val Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp Asn Pro Val Leu Pro    50                  55                  60Phe Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile65                  70                  75                  80Arg Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu                85                  90                  95Leu Ile Val Asn Asn Ala Thr Asn Val Val Ile Lys Val Cys Glu Phe            100                 105                 110Gln Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr Tyr His Lys Asn Asn        115                 120                 125Lys Ser Trp Met Glu Ser Glu Phe Arg Val Tyr Ser Ser Ala Asn Asn    130                 135                 140Cys Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu Met Asp Leu Glu Gly145                 150                 155                 160Lys Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe Val Phe Lys Asn Ile                165                 170                 175Asp Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr Pro Ile Asn Leu Val            180                 185                 190Arg Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu Pro Leu Val Asp Leu        195                 200                 205Pro Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His    210                 215                 220Arg Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser Gly Trp Thr Ala Gly225                 230                 235                 240Ala Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu                245                 250                 255Lys Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala Val Asp Cys Ala Leu            260                 265                 270Asp Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys Ser Phe Thr Val Glu        275                 280                 285Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val Gln Pro Thr Glu Ser    290                 295                 300Ile Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val305                 310                 315                 320Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg                325                 330                 335Ile Ser Asn Cys Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser            340                 345                 350Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp        355                 360                 365Leu Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp    370                 375                 380Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr385                 390                 395                 400Asn Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys Val Ile Ala Trp Asn                405                 410                 415Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr            420                 425                 430Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser        435                 440                 445Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu Gly    450                 455                 460Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn465                 470                 475                 480Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe Glu Leu                485                 490                 495Leu His Ala Pro Ala Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu            500                 505                 510Val Lys Asn Lys Cys Val Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr        515                 520                 525Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe    530                 535                 540Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp Pro Gln Thr545                 550                 555                 560Leu Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe Gly Gly Val Ser Val                565                 570                 575Ile Thr Pro Gly Thr Asn Thr Ser Asn Gln Val Ala Val Leu Tyr Gln            580                 585                 590Asp Val Asn Cys Thr Glu Val Pro Val Ala Ile His Ala Asp Gln Leu        595                 600                 605Thr Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser Asn Val Phe Gln Thr    610                 615                 620Arg Ala Gly Cys Leu Ile Gly Ala Glu His Val Asn Asn Ser Tyr Glu625                 630                 635                 640Cys Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr Gln Thr Gln                645                 650                 655Thr Asn Ser Pro Arg Arg Ala Phe Tyr Pro Ser Tyr His Ser Thr Pro            660                 665                 670Gln Arg Pro        675</s400><s200><s210>24</s210><s211>766</s211><s212>PRT</s212><s213>Artificial Sequence</s213><s220><s223>synthetic</s223></s220></s200><s400> 24Val Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr1               5                   10                  15Tyr Pro Asp Lys Val Phe Arg Ser Ser Val Leu His Ser Thr Gln Asp            20                  25                  30Leu Phe Leu Pro Phe Phe Ser Asn Val Thr Trp Phe His Ala Ile His        35                  40                  45Val Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp Asn Pro Val Leu Pro    50                  55                  60Phe Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile65                  70                  75                  80Arg Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu                85                  90                  95Leu Ile Val Asn Asn Ala Thr Asn Val Val Ile Lys Val Cys Glu Phe            100                 105                 110Gln Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr Tyr His Lys Asn Asn        115                 120                 125Lys Ser Trp Met Glu Ser Glu Phe Arg Val Tyr Ser Ser Ala Asn Asn    130                 135                 140Cys Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu Met Asp Leu Glu Gly145                 150                 155                 160Lys Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe Val Phe Lys Asn Ile                165                 170                 175Asp Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr Pro Ile Asn Leu Val            180                 185                 190Arg Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu Pro Leu Val Asp Leu        195                 200                 205Pro Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His    210                 215                 220Arg Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser Gly Trp Thr Ala Gly225                 230                 235                 240Ala Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu                245                 250                 255Lys Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala Val Asp Cys Ala Leu            260                 265                 270Asp Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys Ser Phe Thr Val Glu        275                 280                 285Lys Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val Gln Pro Thr Glu Ser    290                 295                 300Ile Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val305                 310                 315                 320Phe Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg                325                 330                 335Ile Ser Asn Cys Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser            340                 345                 350Phe Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp        355                 360                 365Leu Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp    370                 375                 380Glu Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr385                 390                 395                 400Asn Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys Val Ile Ala Trp Asn                405                 410                 415Ser Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr            420                 425                 430Arg Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser        435                 440                 445Thr Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu Gly    450                 455                 460Phe Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn465                 470                 475                 480Gly Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe Glu Leu                485                 490                 495Leu His Ala Pro Ala Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu            500                 505                 510Val Lys Asn Lys Cys Val Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr        515                 520                 525Gly Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe    530                 535                 540Gly Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp Pro Gln Thr545                 550                 555                 560Leu Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe Gly Gly Val Ser Val                565                 570                 575Ile Thr Pro Gly Thr Asn Thr Ser Asn Gln Val Ala Val Leu Tyr Gln            580                 585                 590Asp Val Asn Cys Thr Glu Val Pro Val Ala Ile His Ala Asp Gln Leu        595                 600                 605Thr Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser Asn Val Phe Gln Thr    610                 615                 620Arg Ala Gly Cys Leu Ile Gly Ala Glu His Val Asn Asn Ser Tyr Glu625                 630                 635                 640Cys Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr Gln Thr Gln                645                 650                 655Thr Asn Ser Pro Arg Arg Ala Ala Pro Gln Ser Ile Thr Glu Leu Cys            660                 665                 670Ser Glu Tyr His Asn Thr Gln Ile Tyr Thr Ile Asn Asp Lys Ile Leu        675                 680                 685Ser Tyr Thr Glu Ser Met Ala Gly Lys Arg Glu Met Val Ile Ile Thr    690                 695                 700Phe Lys Ser Gly Ala Thr Phe Gln Val Glu Val Pro Gly Ser Gln His705                 710                 715                 720Ile Asp Ser Gln Lys Lys Ala Ile Glu Arg Met Lys Asp Thr Leu Arg                725                 730                 735Ile Thr Tyr Leu Thr Glu Thr Lys Ile Asp Lys Leu Cys Val Trp Asn            740                 745                 750Asn Lys Thr Pro Asn Ser Ile Ala Ala Ile Ser Met Glu Asn        755                 760                 765</s400></sequence-list-new-rules></sequence-cwu><?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v46-2022-02-17.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.6 2022-02-17" file="US20230002781A1-20230105.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20221221" date-publ="20230105"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20230002781</doc-number><kind>A1</kind><date>20230105</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>17781229</doc-number><date>20201204</date></document-id></application-reference><us-application-series-code>17</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>82</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>12</class><subclass>N</subclass><main-group>15</main-group><subgroup>8279</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20230105</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><invention-title id="d2e43">Methods and Compositions for Modifying Plant Immunity</invention-title><us-related-documents><us-provisional-application><document-id><country>US</country><doc-number>62943404</doc-number><date>20191204</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>The Regents of the University of California</orgname><address><city>Oakland</city><state>CA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Krasileva</last-name><first-name>Ksenia Vladimirovna</first-name><address><city>Berkeley</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Prigozhin</last-name><first-name>Daniil M.</first-name><address><city>Berkeley</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Staskawicz</last-name><first-name>Brian J.</first-name><address><city>Berkeley</city><state>CA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Liu</last-name><first-name>Furong</first-name><address><city>Berkeley</city><state>CA</state><country>US</country></address></addressbook></inventor></inventors></us-parties><pct-or-regional-filing-data><document-id><country>WO</country><doc-number>PCT/US2020/063203</doc-number><date>20201204</date></document-id><us-371c12-date><date>20220531</date></us-371c12-date></pct-or-regional-filing-data></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Disclosed herein are methods for identifying amino acid residues of NLRs that are likely involved in pathogen immunity. Also disclosed are methods for modifying plant immunity which comprise modifying (e.g., substituting, deleting, or adding an amino acid before or after) one or more of the amino acid residues that have been identified as being likely involved in pathogen immunity.</p></abstract><drawings id="DRAWINGS"><figure id="Fig-EMI-D00000" num="00000"><img id="EMI-D00000" he="95.42mm" wi="158.75mm" file="US20230002781A1-20230105-D00000.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00001" num="00001"><img id="EMI-D00001" he="232.92mm" wi="101.18mm" orientation="landscape" file="US20230002781A1-20230105-D00001.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00002" num="00002"><img id="EMI-D00002" he="241.30mm" wi="153.25mm" orientation="landscape" file="US20230002781A1-20230105-D00002.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00003" num="00003"><img id="EMI-D00003" he="138.51mm" wi="160.70mm" file="US20230002781A1-20230105-D00003.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00004" num="00004"><img id="EMI-D00004" he="225.04mm" wi="106.68mm" orientation="landscape" file="US20230002781A1-20230105-D00004.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00005" num="00005"><img id="EMI-D00005" he="106.17mm" wi="160.36mm" file="US20230002781A1-20230105-D00005.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00006" num="00006"><img id="EMI-D00006" he="256.96mm" wi="99.23mm" orientation="landscape" file="US20230002781A1-20230105-D00006.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure><figure id="Fig-EMI-D00007" num="00007"><img id="EMI-D00007" he="229.62mm" wi="164.68mm" orientation="landscape" file="US20230002781A1-20230105-D00007.TIF" alt="embedded image" img-content="drawing" img-format="tif"/></figure></drawings><description id="description"><?cross-reference-to-related-applications description="Cross Reference To Related Applications" end="lead"?><heading id="h-0001" level="1">CROSS-REFERENCE TO RELATED APPLICATIONS</heading><p id="p-0002" num="0001">This application claims the benefit of U.S. Patent Application No. 62/943,404, filed Dec. 4, 2019, which is herein incorporated by reference in its entirety.</p><?cross-reference-to-related-applications description="Cross Reference To Related Applications" end="tail"?><?summary-of-invention description="Summary of Invention" end="lead"?><heading id="h-0002" level="1">REFERENCE TO A SEQUENCE LISTING SUBMITTED VIA EFS-WEB</heading><p id="p-0003" num="0002">The content of the ASCII text file of the sequence listing named &#x201c;20201204_034044_213WO1_ST25&#x201d; which is 18.7 kb in size was created on Nov. 29, 2020 and electronically submitted via EFS-Web herewith the application is incorporated herein by reference in its entirety.</p><heading id="h-0003" level="1">BACKGROUND OF THE INVENTION</heading><heading id="h-0004" level="1">1. Field of the Invention</heading><p id="p-0004" num="0003">The field generally relates to recombinant plant immune receptors.</p><heading id="h-0005" level="1">2. Description of the Related Art</heading><p id="p-0005" num="0004">Plant pathogens threaten production of valuable crops. Identification of genetic sources of resistance to pathogens is an active area of both academic and industry-based research and has potential to increase yields and reduce reliance on environmentally damaging chemicals used to control infections. Current methods for finding new resistant plant varieties rely on either naturally occurring immune receptors that need to be crossed into elite varieties or on induced variation produced by random mutagenesis of the whole genome that requires back-crosses to remove unwanted variation. In case of finding new natural variants, traditional approaches rely on genetic mapping and Mendelian genetics, which can take over 5 years even when newest sequencing technologies are used. There is no guarantee that after this process, the identified gene will work on its own in a new variety or how durable it will be. Another way of finding new natural sources of disease resistance is through genome wide association mapping; however, this process will only identify genes if their prevalence in natural populations is above 5% and will miss any rare variants that are key to generation of new pathogen recognition specificities. Finally, new sources of disease resistance can be identified by introducing genetic variation by mutagenesis; this involves generation of a mutagenized population, screening it, isolating the region of interest and then breeding out background mutations, a process that can take 4-6 years and often the causative mutation responsible for the phenotype is not mapped beyond a general genomic region.</p><p id="p-0006" num="0005">Plant immunity is encoded in the germline, a feature plants share with the majority of eukaryotes. Plants deploy hundreds of immune receptors to detect presence of pathogen-derived molecules and elicit an immune response. At the same time, plant pathogens&#x2014;viruses, bacteria, and fungi&#x2014;evolve rapidly to evade immune recognition. The two main classes of plant immune receptors include transmembrane receptor like kinases and pattern recognition receptors that monitor the extracellular environment, and the intracellular Nucleotide Binding Leucine Rich Repeat receptors (NLRs) that can detect pathogen-derived molecules or their activities inside the plant cells. Variation in these receptors on a population level provides the necessary arsenal of pathogen recognition specificities.</p><p id="p-0007" num="0006">Plant NLRs typically comprise three domains: a central Nucleotide Binding (NB-ARC) domain that mediates receptor oligomerization upon activation, a signaling domain, e.g., an N-terminal Toll Interleukin 1 like Receptor (TIR) or Coiled Coil (CC) domain, and the C-terminal Leucine Rich Repeat (LRR) domain that mediates both activating and self-inhibitory protein-protein interactions. NLRs have been shown to recognize pathogens using three main modes. First, direct binding to the pathogen-derived effector molecules with binding specificity commonly encoded in the LRR domain. Second, the indirect recognition of effector activities on other plant proteins, with the NLRs guarding plant proteins targeted by effectors. Third, indirect recognition of modifications to a non-canonical integrated domain of the NLR, which acts as a bait for the effector.</p><heading id="h-0006" level="1">SUMMARY OF THE INVENTION</heading><heading id="h-0007" level="2">Identification Methods</heading><p id="p-0008" num="0007">In some embodiments, the present invention is directed to a method of identifying one or more amino acid residues in a plant immunity receptor that are likely involved in binding its cognate ligand, which comprises determining the Shannon entropy of each amino acid of the receptor; selecting an entropy cutoff value of at least 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, or at least 2.0; and identifying at least one amino acid residue among the amino acid residues having the highest entropy values above the entropy cutoff value. In some embodiments, the entropy cutoff value is at least 1.5. In some embodiments, the Shannon entropy is determined from a plurality of amino acid sequences from homologs of the plant immunity receptor, and the plant immunity receptor and the homologs are of the same plant species. In some embodiments, the plurality of amino acid sequences comprises at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, or at least 80 amino acid sequences. In some embodiments, the plants are genetically diverse. In some embodiments, at least ten amino acid residues having the highest entropy values are identified as being likely involved in binding the cognate ligand. In some embodiments, 5-20, 6-19, 7-18, 8-16, 9-16, or 10-15 amino acid residues having the highest entropy values are identified as being likely involved in binding the cognate ligand. In some embodiments, the method further comprises determining the hydrophobicity of each amino acid of the receptor and identifying one or more of the amino acid residues having the highest entropy values and the highest hydrophobicity as being likely involved in binding the cognate ligand.</p><heading id="h-0008" level="2">Modification Methods</heading><p id="p-0009" num="0008">In some embodiments, the present invention is directed to a method of modifying pathogen recognition, binding, and/or specificity of a plant immunity receptor, which comprises modifying one or more amino acid residues that are identified as being involved in binding the cognate ligand of the plant immunity receptor as described herein, e.g., &#x201c;Identification Methods&#x201d; above. In some embodiments, the one or more amino acid residues are substituted with a different amino acid. In some embodiments, a region of contiguous amino acid residues comprising the one or more amino acid residues is substituted with a region of contiguous amino acid residues obtained from a different plant immunity receptor.</p><p id="p-0010" num="0009">In some embodiments, the present invention is directed to a method of modifying a Sr33 plant immunity receptor, which comprises modifying one or more of the amino acid residues that correspond to amino acid residue positions 703-887 of SEQ ID NO: 1. In some embodiments, the amino acid residue positions are selected from (a) 707, 709, 710, 735, 737, 738, 765, 767, 768, 793, 795, 796, 818, 820, and 821 of SEQ ID NO: 1, or (b) 707, 709, 711, 735, 737, 741, 765, 767, 793, 795, 796, 818, 820, 821, 832, 841, 843, 864, 866, and 880 of SEQ ID NO: 1. In some embodiments, the Sr33 plant immunity receptor comprises at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity to SEQ ID NO: 1.</p><p id="p-0011" num="0010">In some embodiments, the present invention is directed to a method of modifying a plant immunity receptor of <i>Arabidopsis thaliana</i>, which comprises modifying one or more amino acid residues of the plant immunity receptor that correspond the highly variable amino acid residues as set forth in Table 1 or Table 2.</p><heading id="h-0009" level="2">Products</heading><p id="p-0012" num="0011">In some embodiments, the present invention is directed to a plant immunity receptor made or modified as described herein, e.g., &#x201c;Modification Methods&#x201d; above. In some embodiments, the present invention is directed to a nucleic acid molecule that encodes the plant immunity receptor. In some embodiments, the present invention is directed to a vector which comprises the nucleic acid molecule. In some embodiments, the present invention is directed to a cell which comprises the vector. In some embodiments, the present invention is directed to a plant which comprises the plant immunity receptor. In some embodiments, the present invention is directed to a plant which comprises the cell that comprises the vector. In some embodiments, the present invention is directed to a population of plants comprising a plurality of plants which comprise the plant immunity receptor and/or the cell that comprises the vector.</p><p id="p-0013" num="0012">Both the foregoing general description and the following detailed description are exemplary and explanatory only and are intended to provide further explanation of the invention as claimed. The accompanying drawings are included to provide a further understanding of the invention and are incorporated in and constitute part of this specification, illustrate several embodiments of the invention, and together with the description explain the principles of the invention.</p><?summary-of-invention description="Summary of Invention" end="tail"?><?brief-description-of-drawings description="Brief Description of Drawings" end="lead"?><description-of-drawings><heading id="h-0010" level="1">DESCRIPTION OF THE DRAWINGS</heading><p id="p-0014" num="0013">This invention is further understood by reference to the drawings wherein:</p><p id="p-0015" num="0014"><figref idref="DRAWINGS">FIG. <b>1</b></figref> shows the entropy and hydrophobicity of LRRs in Sr33 and amino acid modifications that may be made to modify the pathogen recognition, specificity, and/or binding of the receptor.</p><p id="p-0016" num="0015"><figref idref="DRAWINGS">FIG. <b>2</b></figref> shows that the chimeric receptor Sr3350 (comprising Sr50 leucine-rich repeats residues 8 to 14 grafted onto Sr33) recognizes the pathogen effector AvrSr50. Phenotypes of the hypersensitive response (grey) are visible in the leaves of <i>Nicotiana benthamiana </i>(<i>N. benthamiana</i>) with <i>Agrobacterium</i>-mediated transient expression. Top: Transient expression in <i>N. benthamiana </i>of Sr50, Sr33, Sr3350, AvrSr50, or AvrSr50QCMJC alone. Middle: Transient expression of in <i>N. benthamiana </i>of Sr50, Sr33, Sr3350 with the pathogen effector AvrSr50. Bottom: Transient expression of in <i>N. benthamiana </i>of Sr50, Sr33, Sr3350 with AvrSr50 variant race AvrSr50QCMJC found in <i>Puccinia graminis </i>f. sp. <i>tritici</i>. The binary vector p1776 containing each gene was transformed into <i>Agrobacterium </i>strain GV3101 and inoculated in 4-5 week-old <i>N. benthamiana </i>plants at an OD<sub>600 </sub>of 0.025 for each. Four experimental repeats were performed for each experiment on different plants. The images were taken two days post infection.</p><p id="p-0017" num="0016"><figref idref="DRAWINGS">FIG. <b>3</b></figref> shows allelic swap and cell death assays with AvrSr50 in <i>Triticum aestivum </i>(wheat) protoplasts. The y axis represents luminescence from the luciferase reporter designating live transfected cells, lack of luminescence indicates cell death response. The x axis shows different combinations of constructs tested in wheat protoplasts. N=4 biological replicates, each containing 3 technical replicates. **Paired t-test&#x3c;0.0001.</p><p id="p-0018" num="0017"><figref idref="DRAWINGS">FIG. <b>4</b></figref> shows the entropy and hydrophobicity of LRRs in RPP1 of <i>A. thaliana</i>, and amino acid modifications that may be made to modify the pathogen recognition, specificity, and/or binding of the receptor.</p><p id="p-0019" num="0018"><figref idref="DRAWINGS">FIG. <b>5</b></figref>, <figref idref="DRAWINGS">FIG. <b>6</b></figref>, and <figref idref="DRAWINGS">FIG. <b>7</b></figref> show the entropy and hydrophobicity of LRRs in RPP13 of <i>A. thaliana</i>, and amino acid modifications that may be made to modify the pathogen recognition, specificity, and/or binding of the receptor.</p></description-of-drawings><?brief-description-of-drawings description="Brief Description of Drawings" end="tail"?><?detailed-description description="Detailed Description" end="lead"?><heading id="h-0011" level="1">DETAILED DESCRIPTION OF THE INVENTION</heading><p id="p-0020" num="0019">Disclosed herein are methods for identifying amino acid residues of NLRs that are likely involved in pathogen immunity. Also disclosed are methods for modifying plant immunity which comprise modifying (e.g., substituting, deleting, or adding an amino acid before or after) one or more of the amino acid residues that have been identified as being likely involved in pathogen immunity.</p><p id="p-0021" num="0020">As disclosed herein, Shannon entropy analysis was used to NLRs to identify amino acid residues in NLRs that are likely involved in pathogen recognition, specificity, and/or binding. See Stewart, et al. (1997) Molec Immunol 34(15): 1067-1082. Shannon entropy is given by the formula:</p><p id="p-0022" num="0000"><maths id="MATH-US-00001" num="00001"><math overflow="scroll"> <mrow>  <mi>H</mi>  <mo>=</mo>  <mrow>   <mo>-</mo>   <mrow>    <munderover>     <mo>&#x2211;</mo>     <mrow>      <mi>i</mi>      <mo>=</mo>      <mn>1</mn>     </mrow>     <mn>20</mn>    </munderover>    <mrow>     <msub>      <mi>p</mi>      <mi>i</mi>     </msub>     <mo>&#x2062;</mo>     <msub>      <mi>log</mi>      <mn>2</mn>     </msub>     <mo>&#x2062;</mo>     <msub>      <mi>p</mi>      <mi>i</mi>     </msub>    </mrow>   </mrow>  </mrow> </mrow></math></maths></p><p id="p-0023" num="0000">where pi is the fraction of one of the twenty amino acids in a column of a protein sequence alignment. Shannon entropy calculates the amount of variability at each column, i.e., amino acid position, of a plurality of aligned sequences. Amino acid positions that little amino acid variability have low entropy and amino acid positions that have high amino acid variability have high entropy.</p><p id="p-0024" num="0021">Briefly, the amino acid sequences of a given receptor in at least 60 genetically diverse plants in initial studies (and at least 25 genetically diverse plants in later studies) within a given species were aligned and then the Shannon entropy at each amino acid position was determined. In initial studies, if the given receptor had 15 or more amino acid residues with entropy above a cutoff of 1.5, the receptor was classed as highly variable and the top 10-15 amino acids with highest entropy were found to be involved in pathogen recognition, specificity, and/or binding. In later studies, if the given receptor had 15 or more amino acid residues with entropy above a cutoff of 1.5, the receptor was classed as highly variable and amino acids entropy above a cutoff of 1.5 were found to be involved in pathogen recognition, specificity, and/or binding.</p><heading id="h-0012" level="2">Shannon Entropy to Identify Highly Variable Residues in Immune Receptors</heading><p id="p-0025" num="0022">To test if Shannon entropy can serve as a valid measure to detect specificity-determining residues in immune receptors, we tested it on two well studied systems: human antibody and the variable leukocyte receptor from lampreys. In the case of the antibody, we restricted our analysis to the Fab fragment of a known IgG antibody. By aligning sequences of homologs of the IgG antibody as deposited in RCSB Protein Data Bank (rcsb.org) for both heavy and light chains, and calculating the entropy scores for individual positions, we observed that residues with the highest variability scores occurred in the N-termini of both the heavy and light chains and coincided with their complementarity determining regions (CDRs). Similar analysis of the lamprey VLR, the receptor molecule in the lamprey adaptive immune system, highlighted the concave side of the leucine rich repeat domain as the location for the most diverse surface residues in these receptors. These results are consistent with information of the binding sites as provided in the art.</p><heading id="h-0013" level="2">Sr33/Sr50 Receptor Family</heading><heading id="h-0014" level="2">Sr33/Sr50 Binding Site Prediction</heading><p id="p-0026" num="0023">To confirm that Shannon entropy analysis may be used to identify the sites in plant immunity receptors that are likely involved in pathogen recognition and binding, the Sr33/Sr50 family of receptors from Triticiea was used because its members directly bind a diverse array of pathogens. BLAST sequence searches of publicly available databases were performed to select about 100 homologs of Sr50. The selected sequences were aligned and the entropy scores of each aligned amino acid residue was calculated using methods in the art. Specifically, the alignments were filtered to exclude outliers using R and OD-seq (Jehl, et al. 2015). The filtered alignments were scored using a Shannon's entropy function (Shannon &#x26; Weaver 1949) that generates a numerical score for each position in the alignment.</p><p id="p-0027" num="0024">Aligned amino acid residues that consistently exceed a score cutoff of 1.5 bits were classed as highly variable and were hypothesized as being involved in the binding and recognition of pathogen molecules. The highly variable residues were cross-checked against surface prediction of the LRR domain and hydrophobicity. Sets of 10-15 amino acid residues that were predicted to cluster on the surface of the receptor were investigated for presence of exposed aromatic and hydrophobic residues in the natural sequences. Clusters that show high variability (entropy scores) and a core of exposed hydrophobic residues are considered as candidate specificity-determining regions of the plant immune receptor. <figref idref="DRAWINGS">FIG. <b>1</b></figref> shows the entropy and hydrophobicity of LRRs in Sr33 and amino acid modifications that may be made to modify the pathogen recognition, specificity, and/or binding of the receptor.</p><p id="p-0028" num="0025">Similarly, the LRR domain of Sr33 (amino acid residues 703-887 of AGQ17390.1) was determined. Using methods in the art, the LRR domain of Sr33 was substituted with the LRR domain of Sr50 (amino acid residues 707-891 of ALO61074.1) to result in a chimeric receptor, &#x201c;Sr3350&#x201d;. Using a co-infiltration assay in <i>N. benthamiana </i>known in the art, the chimeric receptor Sr3350 was found to recognize the cognate target of Sr50, i.e., AvrSr50. See <figref idref="DRAWINGS">FIG. <b>2</b></figref>. Using protoplast transfection assay in <i>Triticum aestivum </i>known in the art, the chimeric receptor Sr3350 was found to recognize AvrSr50, the co-transfection of Sr3350 and AvrSr50 produced statistically significant more protoplast cell death (Paired t-test&#x3c;0.0001) than transfection of Sr3350 alone. See <figref idref="DRAWINGS">FIG. <b>3</b></figref>.</p><p id="p-0029" num="0026">These experiments indicate Shannon entropy analysis may be used to identify one or more amino acid residues in a plant immune receptor which are involved in pathogen recognition and specificity, and which may be modified to change the pathogen recognition and specificity of the receptors. For example, amino acid residues 707, 709, 710, 735, 737, 738, 765, 767, 768, 793, 795, 796, 818, 820, and 821 of Sr33 were identified as being highly variable. Using a strict 1.5 bit score cutoff, amino acid residues 707, 709, 711, 735, 737, 741, 765, 767, 793, 795, 796, 818, 820, 821, 832, 841, 843, 864, 866, and 880 of Sr33 were identified as being highly variable. As such, the pathogen recognition, specificity, and/or binding of Sr33 may be modified by modifying one or more of these residues in any combination. In some embodiments, one highly variable amino acid residue is modified. In some embodiments, two or more highly variable amino acid residues are modified. In some embodiments, three or more highly variable amino acid residues are modified. In some embodiments, four or more highly variable amino acid residues are modified. In some embodiments, five or more highly variable amino acid residues are modified. In some embodiments, six or more highly variable amino acid residues are modified. In some embodiments, seven or more highly variable amino acid residues are modified. In some embodiments, eight or more highly variable amino acid residues are modified. In some embodiments, nine or more highly variable amino acid residues are modified. In some embodiments, ten or more or more highly variable amino acid residues are modified.</p><heading id="h-0015" level="2">Highly Variable NLRs in <i>Arabidopsis Thaliana </i></heading><p id="p-0030" num="0027">Phylogenetic analysis was used to group the published NLRome into clades that were large enough to preserve the variability signal while being amenable to full-length de novo alignment. Shannon entropy was used to collapse the sequence alignments into simple 2D graphs while highlighting areas of increased diversity. The annotation of individual Leucine Rich Repeat motifs in the LRR domain combined with the variability analysis highlighted amino acid residues in the LRR domain that are likely involved in pathogen recognition specificity.</p><p id="p-0031" num="0028">The results herein show that around 30% of all <i>Arabidopsis </i>NLRs belong to rapidly diversifying families and are therefore candidates for direct recognition. These are distributed in the NLR phylogeny among both CC- and TIR-dependent NLRs. The results further show that, in the twelve clades that contain highly variably NLRs (hvNLRs), the highly variable residues are positioned near each other in a &#x201c;cluster&#x201d; on the surface of the NLRs, but the locations of the clusters are not conserved between different families of NLRs.</p><heading id="h-0016" level="2"><i>Arabidopsis </i>NLRome Shows Variable Rates of NLR Diversification</heading><p id="p-0032" num="0029">Unlike the receptors of animal adaptive immunity such as the antibody, the T-cell receptor, and the lamprey VLR, plant immune receptor specificities are germline encoded. To carry out variability analyses on NLR clades of <i>A. thaliana</i>, we identified groups of closely related NLR's within the overall NLR phylogeny that were close enough in sequence to produce high quality alignments, yet large enough to preserve the variability signal using methods in the art. See, e.g., Bailey et al. First, an overall NLR phylogeny was constructed on the basis of only the NB-ARC domain, and clades with strong bootstrapping were identified. Second, the full-length sequences of identified clades were optimally aligned, and the alignments were evaluated by Shannon entropy analysis and assigned entropy scores. Clades that produced high variability scores were marked for further splitting on the basis of phylogenetic trees built on the full-length alignment. Because exclusion of more distantly related sequences improves alignment, the process was repeated for several subclades to produce a final clade assignment, in which most clades had very low average entropy scores and most contained 70 or fewer members, with few containing more than one gene from a given ecotype.</p><p id="p-0033" num="0030">The highly variable amino acid residues identified in the highly variable genes of <i>Arabidopsis thaliana </i>as described herein are provided in Table 1 and Table 2.</p><p id="p-0034" num="0000"><tables id="TABLE-US-00001" num="00001"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="392pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 1</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Highly variable immune genes from <i>Arabidopsis thaliana</i></entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="4"><colspec colname="1" colwidth="49pt" align="left"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="35pt" align="left"/><colspec colname="4" colwidth="252pt" align="left"/><tbody valign="top"><row><entry/><entry/><entry>NB-ARC</entry><entry/></row><row><entry>Accession No.</entry><entry>Uniprot No.</entry><entry>Residues</entry><entry>Highly Variable Amino Acid Residues</entry></row><row><entry namest="1" nameend="4" align="center" rowsep="1"/></row><row><entry>AT1G31540.1</entry><entry>F4I9F1_ARATH</entry><entry>183-454</entry><entry>636, 637, 659, 660, 662, 683, 684, 704, 706, 707, 727, 728, 741, 745, 751</entry></row><row><entry>AT1G31540.2</entry><entry/><entry>183-454</entry><entry>636, 659, 684, 706, 707, 727, 780, 782, 802, 806, 807, 869, 1008, 1035, 1037</entry></row><row><entry>AT1G58602.1</entry><entry>DRL9_ARATH</entry><entry>163-511</entry><entry>735, 737, 761, 808, 832, 856, 857, 879, 923, 968, 970, 995, 996, 1014, 1040</entry></row><row><entry>AT1G58602.2</entry><entry/><entry>163-511</entry><entry>735, 737, 761, 808, 832, 856, 857, 879, 923, 968, 970, 995, 996, 1014, 1040</entry></row><row><entry>AT1G58807.1</entry><entry>DRL10_ARATH</entry><entry>164-507</entry><entry>565, 634, 635, 659, 729, 802, 826, 848, 850, 873, 874, 895, 923, 944, 968</entry></row><row><entry>AT1G58807.2</entry><entry/><entry>164-507</entry><entry>565, 634, 635, 659, 677, 727, 729, 731, 755, 801, 802, 826, 848, 850, 852</entry></row><row><entry>AT1G58848.1</entry><entry>DRL11_ARATH</entry><entry>164-507</entry><entry>643, 644, 667, 737, 810, 834, 858, 859, 881, 882, 928, 930, 973, 975, 1021</entry></row><row><entry>AT1G58848.2</entry><entry/><entry>164-507</entry><entry>643, 644, 667, 737, 810, 834, 858, 859, 881, 882, 928, 930, 973, 975, 1021</entry></row><row><entry>AT1G59124.1</entry><entry>DRL44_ARATH</entry><entry>164-507</entry><entry>565, 634, 635, 659, 677, 727, 729, 731, 755, 801, 802, 826, 848, 850, 852</entry></row><row><entry>AT1G59218.1</entry><entry>DRL45_ARATH</entry><entry>164-507</entry><entry>643, 644, 667, 737, 810, 834, 858, 859, 881, 882, 928, 930, 973, 975, 1021</entry></row><row><entry>AT1G59218.2</entry><entry/><entry>164-507</entry><entry>643, 644, 667, 737, 810, 834, 858, 859, 881, 882, 928, 930, 973, 975, 1021</entry></row><row><entry>AT1G61180.1</entry><entry>Q2V4G0_ARATH</entry><entry>155-482</entry><entry><u style="single">419, 467</u>, 520, 542, 590, 615, 679, 681, 742, 744, 763, 765, 767, 821, 823</entry></row><row><entry>AT1G61180.2</entry><entry/><entry>155-482</entry><entry><u style="single">419, 467</u>, 520, 542, 590, 615, 679, 681, 742, 744, 763, 765, 767, 821, 823</entry></row><row><entry>AT1G61190.1</entry><entry>DRL16_ARATH</entry><entry>156-486</entry><entry><u style="single">420, 425</u>, 524, 546, 594, 619, 683, 685, 748, 750, 769, 771, 773, 828, 830</entry></row><row><entry>AT1G61300.1</entry><entry>DRL17_ARATH</entry><entry>44-371</entry><entry><u style="single">308, 356</u>, 409, 431, 479, 504, 567, 569, 630, 632, 651, 653, 655, 709, 711</entry></row><row><entry>AT1G61310.1</entry><entry>DRL18_ARATH</entry><entry>157-495</entry><entry><u style="single">421, 480</u>, 533, 555, 603, 628, 692, 694, 755, 757, 776, 778, 780, 834, 836</entry></row><row><entry>AT1G62630.1</entry><entry>DRL14_ARATH</entry><entry>153-486</entry><entry><u style="single">472</u>, 557, 581, 626, 700, 723, 725, 726, 747, 772, 773, 828, 891, 892, 893</entry></row><row><entry>AT1G63360.1</entry><entry>DRL20_ARATH</entry><entry>153-486</entry><entry><u style="single">472</u>, 555, 579, 624, 698, 721, 723, 724, 745, 770, 771, 802, 826, 883, 884</entry></row><row><entry>AT1G69550.1</entry><entry>F4I270_ARATH</entry><entry>255-517</entry><entry>678, 679, 720, 792, 796, 816, 820, 840, 844, 864, 890, 893, 911, 938, 940</entry></row><row><entry>AT2G14080.1</entry><entry>F4IFF6_ARATH</entry><entry>230-495</entry><entry>581, 637, 659, 660, 680, 683, 754, 778, 797, 825, 826, 959, 1150, 1153, 1155</entry></row><row><entry>AT3G44400.1</entry><entry>Q9M285_ARATH</entry><entry>214-483</entry><entry><u style="single">472</u>, 509, 634, 656, 681, 725, 815, 882, 937, 938, 939, 941, 943, 962, 1007</entry></row><row><entry>AT3G44400.2</entry><entry/><entry>214-483</entry><entry><u style="single">472</u>, 509, 634, 656, 681, 725, 815, 882, 937, 938, 939, 941, 943, 962, 1007</entry></row><row><entry>AT3G44480.1</entry><entry>RPP1_ARATH</entry><entry>273-542</entry><entry><u style="single">531</u>, 568, 678, 769, 835, 859, 862, 882, 927, 970, 1091, 1092, 1093, 1109, 1150</entry></row><row><entry>AT3G44630.1</entry><entry>F4J359_ARATH</entry><entry>269-597</entry><entry><u style="single">527, 591</u>, 703, 771, 884, 887, 907, 952, 996, 1063, 1118, 1119, 1124, 1172, 1173</entry></row><row><entry>AT3G44630.2</entry><entry/><entry>269-597</entry><entry><u style="single">527, 591</u>, 703, 771, 884, 887, 907, 952, 996, 1063, 1118, 1119, 1124, 1172, 1173</entry></row><row><entry>AT3G44630.3</entry><entry/><entry>269-597</entry><entry><u style="single">527, 591</u>, 703, 771, 884, 887, 907, 952, 996, 1063, 1118, 1119, 1124, 1172, 1173</entry></row><row><entry>AT3G44670.1</entry><entry>F4J361_ARATH</entry><entry>269-530</entry><entry><u style="single">527</u>, 570, 653, 680, 771, 883, 886, 906, 939, 1006, 1061, 1064, 1071, 1091, 1125</entry></row><row><entry>AT3G44670.2</entry><entry/><entry>269-530</entry><entry><u style="single">527</u>, 570, 653, 680, 771, 883, 886, 906, 939, 1006, 1061, 1064, 1071, 1091, 1125</entry></row><row><entry>AT3G46530.1</entry><entry>RPP13_ARATH</entry><entry>163-498</entry><entry>553, 554, 573, 619, 620, 622, 624, 684, 712, 788, 792, 811, 813, 814, 815</entry></row><row><entry>AT4G16860.1</entry><entry>RPP4_ARATH</entry><entry>185-446</entry><entry><u style="single">426</u>, 461, 473, 529, 531, 575, 594, 638, 661, 775, 776, 798, 818, 954, 1000</entry></row><row><entry>AT4G16890.1</entry><entry>SNC1_ARATH</entry><entry>183-454</entry><entry><u style="single">424</u>, 459, 471, 507, 527, 528, 529, 558, 574, 577, 621, 644, 800, 1003, 1070</entry></row><row><entry>AT4G16920.1</entry><entry>Q9SUK4_ARATH</entry><entry>181-442</entry><entry>422, 457, 469, 525, 527, 558, 577, 621, 622, 644, 664, 756, 781, 782, 937</entry></row><row><entry>AT4G16940.1</entry><entry>F4JNB6_ARATH</entry><entry>143-403</entry><entry><u style="single">384, 391</u>, 423, 435, 471, 487, 549, 594, 596, 597, 687, 748, 750, 903, 906</entry></row><row><entry>AT4G16950.1</entry><entry>RPP5_ARATH</entry><entry>188-453</entry><entry>463, 475, 531, 533, 564, 583, 627, 650, 764, 787, 788, 989, 1079, 1198, 1263</entry></row><row><entry>AT4G16950.2</entry><entry/><entry>188-453</entry><entry>463, 475, 531, 533, 564, 583, 627, 650, 764, 787, 788, 989, 1079, 1198, 1263</entry></row><row><entry>AT4G16960.1</entry><entry>O23536_ARATH</entry><entry>187-447</entry><entry>96, <u style="single">428, 435</u>, 467, 479, 515, 569, 614, 616, 617, 705, 766, 768, 921, 924</entry></row><row><entry>AT5G38350.1</entry><entry>Q9FF28_ARATH</entry><entry>26-290</entry><entry>291, 387, 461, 463, 505, 509, 523, 529, 531, 620, 661, 684, 686, 788, 816</entry></row><row><entry>AT5G41740.1</entry><entry>F4JYI4_ARATH</entry><entry>176-439</entry><entry>576, 620, 623, 641, 643, 644, 646, 729, 754, 794, 815, 840, 908, 914, 1010</entry></row><row><entry>AT5G41740.2</entry><entry/><entry>176-439</entry><entry>576, 620, 623, 641, 643, 644, 646, 729, 754, 794, 815, 840, 908, 914, 1010</entry></row><row><entry>AT5G41750.1</entry><entry>Q9LSX5_ARATH</entry><entry>186-447</entry><entry>590, 634, 637, 655, 657, 658, 660, 743, 767, 807, 828, 853, 921, 927, 1068</entry></row><row><entry>AT5G41750.2</entry><entry/><entry>186-447</entry><entry>590, 634, 637, 655, 657, 658, 660, 743, 767, 807, 828, 853, 921, 927, 1068</entry></row><row><entry>AT5G43470.1</entry><entry>RPP8_ARATH</entry><entry>165-502</entry><entry><u style="single">443, 485, 486</u>, 610, 632, 678, 698, 776, 778, 779, 800, 802, 803, 804, 825</entry></row><row><entry>AT5G43470.2</entry><entry/><entry>165-502</entry><entry><u style="single">443, 485, 486</u>, 610, 632, 678, 698, 776, 778, 779, 800, 802, 803, 804, 825</entry></row><row><entry>AT5G43740.1</entry><entry>DRL33_ARATH</entry><entry>155-481</entry><entry>519, 521, 545, 568, 590, 615, 639, 688, 712, 774, 776, 777, 809, 813, 814</entry></row><row><entry>AT5G43740.2</entry><entry/><entry>155-481</entry><entry>519, 521, 545, 568, 590, 615, 639, 688, 712, 774, 776, 777, 809, 813, 814</entry></row><row><entry>AT5G46490.2</entry><entry/><entry>183-452</entry><entry><u style="single">225, 265, 274, 284</u>, 465, 518, 536, 563, 646, 663, 706, 723, 725, 746, 749</entry></row><row><entry>AT5G46510.1</entry><entry>Q9FHF4_ARATH</entry><entry>184-455</entry><entry><u style="single">102, 126</u>, 565, 710, 724, 746, 799, 801, 873, 1015, 1020, 1039, 1041, 1083, 1085</entry></row><row><entry>AT5G46520.1</entry><entry>VICTR_ARATH</entry><entry>185-456</entry><entry><u style="single">103, 127</u>, 566, 711, 725, 747, 800, 802, 874, 1016, 1021, 1040, 1042, 1084, 1086</entry></row><row><entry>AT5G48620.1</entry><entry>RP8L4_ARATH</entry><entry>165-502</entry><entry><u style="single">443, 485, 486</u>, 610, 632, 678, 698, 776, 778, 779, 800, 802, 803, 804, 825</entry></row><row><entry namest="1" nameend="4" align="center" rowsep="1"/></row><row><entry namest="1" nameend="4" align="left" id="FOO-00001">Amino acid residues in the NB-ARC domain are underlined and the remaining residues are located in the LRR region.</entry></row></tbody></tgroup></table></tables></p><p id="p-0035" num="0000"><tables id="TABLE-US-00002" num="00002"><table frame="none" colsep="0" rowsep="0" pgwide="1"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="406pt" align="center"/><thead><row><entry namest="1" nameend="1" rowsep="1">TABLE 2</entry></row></thead><tbody valign="top"><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Highly variable immune genes from <i>Arabidopsis thaliana</i></entry></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="7"><colspec colname="1" colwidth="49pt" align="left"/><colspec colname="2" colwidth="56pt" align="left"/><colspec colname="3" colwidth="42pt" align="center"/><colspec colname="4" colwidth="49pt" align="center"/><colspec colname="5" colwidth="49pt" align="center"/><colspec colname="6" colwidth="105pt" align="center"/><colspec colname="7" colwidth="56pt" align="center"/><tbody valign="top"><row><entry/><entry>Common</entry><entry/><entry/><entry/><entry/><entry/></row><row><entry>Gene</entry><entry>Name</entry><entry>preNB</entry><entry>NB-ARC</entry><entry>linker</entry><entry>LRR</entry><entry>post-LRR</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row><row><entry>AT1G31540.2</entry><entry>RPP9</entry><entry/><entry/><entry/><entry>636, 659, 660, 662, 683, 684,</entry><entry>1006, 1008, 1009,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>706, 707, 727, 728, 778, 780,</entry><entry>1011, 1035, 1036,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>782, 783, 802, 804, 806, 807,</entry><entry>1037, 1038, 1044,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>829, 846, 851, 869, 897</entry><entry>1046</entry></row><row><entry>AT1G58602.1</entry><entry>RPP7</entry><entry/><entry/><entry>570</entry><entry>616, 638, 643, 665, 735, 737,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>759, 761, 784, 807, 808, 809,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>832, 856, 857, 879, 887, 923,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>949, 968, 970, 971, 993, 995,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>996, 1014, 1016, 1040, 1062,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1064, 1065, 1085, 1087</entry></row><row><entry>AT1G58807.1</entry><entry/><entry>49</entry><entry/><entry/><entry>565, 566, 635, 636, 638, 659,</entry><entry>&#x2002;996</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>677, 727, 729, 731, 755, 801,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>802, 826, 848, 850, 851, 861,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>873, 874, 895, 897, 918, 922,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>923, 944, 946, 947, 968</entry></row><row><entry>AT1G58848.1</entry><entry/><entry>49</entry><entry/><entry/><entry>573, 576, 641, 642, 644, 667,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>685, 735, 737, 739, 763, 809,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>810, 834, 856, 858, 859, 869,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>881, 882, 903, 905, 907, 910,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>928, 930, 952, 954, 955, 971,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>975, 976, 997, 999, 1000, 1021</entry></row><row><entry>AT1G59124.1</entry><entry/><entry>49</entry><entry/><entry/><entry>565, 566, 635, 636, 638, 659,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>677, 727, 729, 731, 755, 801,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>802, 826, 848, 850, 851</entry></row><row><entry>AT1G59218.1</entry><entry/><entry>49</entry><entry/><entry/><entry>573, 576, 641, 642, 644, 667,</entry><entry>1049</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>685, 735, 737, 739, 763, 809,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>810, 834, 856, 858, 859, 869,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>881, 882, 903, 905, 907, 910,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>928, 930, 952, 954, 955, 971,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>975, 976, 997, 999, 1000, 1021</entry></row><row><entry>AT1G61180.1</entry><entry/><entry>15, 19</entry><entry>418, 419, 421,</entry><entry/><entry>520, 522, 542, 566, 568, 590,</entry></row><row><entry/><entry/><entry/><entry>424, 465, 467,</entry><entry/><entry>612, 613, 615, 636, 659, 679,</entry></row><row><entry/><entry/><entry/><entry>468</entry><entry/><entry>681, 683, 703, 705, 707, 722,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>740, 742, 744, 745, 763, 765,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>767, 795, 797, 799, 800, 819,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>821, 823, 824, 847, 850</entry></row><row><entry>AT1G61190.1</entry><entry>RPP39</entry><entry>16, 20</entry><entry>419, 420, 422,</entry><entry/><entry>524, 526, 546, 570, 572, 594,</entry></row><row><entry/><entry/><entry/><entry>425</entry><entry/><entry>616, 617, 619, 640, 663, 683,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>685, 687, 707, 709, 711, 728,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>746, 748, 750, 751, 769, 771,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>773, 802, 804, 806, 807, 826,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>828, 830, 831, 854, 856, 897</entry></row><row><entry>AT1G61300.1</entry><entry/><entry>17, 21</entry><entry>307, 308, 310,</entry><entry/><entry>409, 411, 431, 455, 457, 479,</entry></row><row><entry/><entry/><entry/><entry>313, 354, 356,</entry><entry/><entry>501, 502, 504, 525, 548, 567,</entry></row><row><entry/><entry/><entry/><entry>357</entry><entry/><entry>569, 571, 591, 593, 595, 610,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>628, 630, 632, 633, 651, 653,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>655, 683, 685, 687, 688, 707,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>709, 711, 712, 735, 737</entry></row><row><entry>AT1G61310.1</entry><entry/><entry>17, 21</entry><entry>420, 421, 423,</entry><entry/><entry>533, 535, 555, 579, 581, 603,</entry></row><row><entry/><entry/><entry/><entry>426, 467, 469,</entry><entry/><entry>625, 626, 628, 649, 672, 692,</entry></row><row><entry/><entry/><entry/><entry>481</entry><entry/><entry>694, 696, 716, 718, 720, 735,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>753, 755, 757, 758, 776, 778,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>780, 808, 810, 812, 813, 832,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>834, 836, 837, 860, 862</entry></row><row><entry>AT1G62630.1</entry><entry/><entry/><entry>271, 467, 468,</entry><entry/><entry>546, 548, 557, 579, 581, 603,</entry><entry>855, 881</entry></row><row><entry/><entry/><entry/><entry>472</entry><entry/><entry>605, 626, 700, 705, 723, 725,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>726, 747, 750, 772, 773, 791,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>804, 806, 807, 828, 830</entry></row><row><entry>AT1G69550.1</entry><entry/><entry/><entry>549, 550</entry><entry>631, 633</entry><entry>678, 679, 693, 701, 704, 720,</entry><entry>1341</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>722, 725, 743, 748, 772, 791,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>792, 796, 797, 815, 816, 818,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>820, 840, 842, 844, 863, 864,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>865, 866, 868, 869, 887, 892,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>893, 911, 912, 914, 916, 936,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>941, 960, 962, 965, 989, 1032,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1056, 1060, 1061, 1080, 1082,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1084, 1085, 1126, 1127, 1129,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1132, 1150, 1155, 1220, 1222</entry></row><row><entry>AT2G14080.1</entry><entry>RPP28</entry><entry>177&#x2002;</entry><entry/><entry>558</entry><entry>581, 637, 659, 660, 680, 682,</entry><entry>1128, 1150, 1153,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>683, 754, 778, 797, 801, 802,</entry><entry>1155, 1214</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>821, 849, 852, 868, 930, 959</entry></row><row><entry>AT3G44400.1</entry><entry/><entry>&#x2003;8, 191</entry><entry>223, 472, 507,</entry><entry>565, 566, 581</entry><entry>588, 591, 592, 594, 610, 613,</entry><entry>856, 858, 860,</entry></row><row><entry/><entry/><entry/><entry>509</entry><entry/><entry>633, 634, 656, 679, 681, 701,</entry><entry>881, 882, 883,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>702, 725, 726, 748, 767, 771,</entry><entry>884, 935, 937,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>790, 815, 817, 835</entry><entry>938, 939, 941,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry/><entry>943, 960, 961,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry/><entry>962, 994, 1004</entry></row><row><entry>AT3G44480.1</entry><entry>RPP1</entry><entry>4, 65, 241</entry><entry>282, 531, 563,</entry><entry>624, 625, 640</entry><entry>647, 649, 651, 677, 678, 700,</entry><entry>1011, 1013, 1015,</entry></row><row><entry/><entry/><entry/><entry>564, 566, 568</entry><entry/><entry>723, 725, 745, 746, 769, 770,</entry><entry>1034, 1035, 1036,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>787, 790, 792, 811, 812, 835,</entry><entry>1089, 1091, 1093,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>836, 859, 860, 862, 864, 882,</entry><entry>1095, 1097, 1148,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>903, 904, 906, 908, 927, 948,</entry><entry>1149, 1150, 1151,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>950, 953, 970, 972, 990</entry><entry>1187, 1188</entry></row><row><entry>AT3G44630.1</entry><entry/><entry>4, 56, 237</entry><entry>278, 527, 560,</entry><entry>647, 648, 663</entry><entry>670, 672, 673, 674, 702, 703,</entry><entry>1037, 1039, 1041,</entry></row><row><entry/><entry/><entry/><entry>562, 589, 591</entry><entry/><entry>725, 748, 750, 771, 772, 794,</entry><entry>1062, 1063, 1064,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>812, 815, 817, 836, 837, 860,</entry><entry>1116, 1118, 1122,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>861, 884, 885, 887, 889, 907,</entry><entry>1124, 1171, 1172,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>928, 929, 931, 933, 952, 973,</entry><entry>1173, 1174, 1211</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>975, 979, 996, 998, 1016</entry></row><row><entry>AT3G44670.1</entry><entry/><entry>4, 56, 60,</entry><entry>278, 426, 527,</entry><entry>626, 627, 642</entry><entry>649, 651, 652, 653, 654, 656,</entry><entry>984, 1005, 1006,</entry></row><row><entry/><entry/><entry>237</entry><entry>570</entry><entry/><entry>679, 680, 702, 725, 727, 747,</entry><entry>1058, 1060, 1061,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>748, 771, 772, 794, 813, 817,</entry><entry>1062, 1064, 1069,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>835, 838, 840, 860, 883, 884,</entry><entry>1071, 1089, 1090,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>906, 939, 941, 959, 980</entry><entry>1091, 1123, 1124,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry/><entry>1125, 1126, 1170,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry/><entry>1216</entry></row><row><entry>AT3G46530.1</entry><entry>RPP13</entry><entry/><entry/><entry>534</entry><entry>553, 554, 558, 573, 575, 576,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>595, 598, 599, 618, 619, 620,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>622, 624, 641, 684, 686, 689,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>711, 713, 716, 717, 742, 743,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>766, 767, 769, 788, 790, 792,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>793, 811, 814, 815</entry></row><row><entry>AT4G16860.1</entry><entry>RPP4</entry><entry>4, 54, 162</entry><entry>198, 241, 378,</entry><entry>509, 528, 529,</entry><entry>558, 559, 562, 568, 591, 593,</entry><entry>1114</entry></row><row><entry/><entry/><entry/><entry>461, 473</entry><entry>530, 531</entry><entry>594, 616, 634, 638, 639, 641,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>661, 683, 705, 722, 726, 728,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>730, 748, 753, 755, 771, 773,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>775, 776, 794, 798, 799, 840,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>860, 862, 875, 894, 931, 951,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>953, 954, 956, 975, 1000, 1019,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1021, 1066, 1069</entry></row><row><entry>AT4G16890.1</entry><entry>SNC1</entry><entry>52, 92, 93,</entry><entry>196, 239, 376,</entry><entry>507, 526, 527,</entry><entry>555, 556, 574, 576, 577, 599,</entry><entry>1185, 1187, 1188,</entry></row><row><entry/><entry/><entry>94, 96, 160</entry><entry>459, 471</entry><entry>528, 529</entry><entry>617, 621, 622, 624, 644, 686,</entry><entry>1291, 1296</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>706, 708, 712, 713, 714, 721,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>740, 777, 797, 799, 800, 802,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>821, 846, 855, 867, 1048, 1070,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1089, 1091, 1136, 1139</entry></row><row><entry>AT4G16920.1</entry><entry/><entry>4, 50, 90,</entry><entry>194, 237, 374,</entry><entry>505, 524, 525,</entry><entry>553, 554, 557, 574, 576, 577,</entry><entry>1187, 1191, 1294</entry></row><row><entry/><entry/><entry>91, 92, 94,</entry><entry>457, 469</entry><entry>526, 527</entry><entry>599, 617, 621, 622, 624, 644,</entry></row><row><entry/><entry/><entry>158</entry><entry/><entry/><entry>666, 688, 705, 709, 711, 713,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>731, 736, 738, 754, 756, 758,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>759, 777, 781, 782, 823, 843,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>849, 850, 851, 858, 877, 914,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>934, 936, 937, 939, 958, 960,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>961, 983, 984, 1048, 1073, 1092,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1094, 1139, 1142</entry></row><row><entry>AT4G16950.1</entry><entry>RPP5</entry><entry>3, 53, 93,</entry><entry>201, 243, 380,</entry><entry>511, 530, 531,</entry><entry>559, 560, 580, 582, 583, 605,</entry><entry>1201, 1263, 1287,</entry></row><row><entry/><entry/><entry>94, 95, 97,</entry><entry>463, 475</entry><entry>532, 533</entry><entry>623, 627, 628, 630, 650, 672,</entry><entry>1323, 1325, 1326,</entry></row><row><entry/><entry/><entry>165</entry><entry/><entry/><entry>694, 711, 715, 717, 719, 737,</entry><entry>1430, 1435</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>742, 744, 760, 762, 764, 765,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>783, 787, 788, 829, 849, 855,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>857, 942, 943, 990, 1007, 1035,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>1079, 1098, 1100, 1145, 1148</entry></row><row><entry>AT5G38350.1</entry><entry/><entry/><entry>287, 291, 324</entry><entry>387</entry><entry>461, 463, 505, 521, 529, 531,</entry><entry>764, 765, 772,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>533, 620, 642, 661, 684, 685,</entry><entry>780, 788, 816</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>686</entry></row><row><entry>AT5G41740.1</entry><entry>SSI4-LIKE</entry><entry/><entry>337, 435</entry><entry/><entry>551, 552, 576, 587, 623, 639,</entry><entry>914, 915,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>641, 643, 644, 646, 668, 690,</entry><entry>917, 1046</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>707, 712, 729, 754, 777, 794,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>815, 818, 840</entry></row><row><entry>AT5G41750.1</entry><entry/><entry/><entry>346, 444</entry><entry/><entry>590, 601, 637, 653, 655, 657,</entry><entry>927, 928</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>658, 660, 682, 704, 721, 726,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>743, 767, 790, 807, 828, 831,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>853</entry></row><row><entry>AT5G43470.1</entry><entry>RPP8</entry><entry/><entry>429, 440, 442,</entry><entry/><entry>558, 609, 610, 632, 658, 659,</entry></row><row><entry/><entry/><entry/><entry>443, 481, 484,</entry><entry/><entry>678, 698, 700, 773, 776, 778,</entry></row><row><entry/><entry/><entry/><entry>485, 486, 487,</entry><entry/><entry>779, 800, 802, 803, 804, 825,</entry></row><row><entry/><entry/><entry/><entry>488</entry><entry/><entry>875</entry></row><row><entry>AT5G43740.1</entry><entry/><entry/><entry>229, 467</entry><entry>519, 521</entry><entry>543, 545, 568, 569, 590, 615,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>617, 636, 637, 639, 688, 709,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>711, 712, 749, 751, 753, 772,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>774, 776, 777, 809, 811, 813,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>814, 833, 834</entry></row><row><entry>AT5G46510.1</entry><entry/><entry>102&#x2002;</entry><entry>417</entry><entry>565</entry><entry>710, 724, 746, 748, 799, 801,</entry><entry>1015, 1020, 1039,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>826</entry><entry>1041, 1083, 1085</entry></row><row><entry>AT5G46520.1</entry><entry>VICTR-ACQOS</entry><entry>103&#x2002;</entry><entry>418</entry><entry>566</entry><entry>711, 725, 747, 749, 800, 802,</entry><entry>1016, 1021, 1040,</entry></row><row><entry/><entry/><entry/><entry/><entry/><entry>827</entry><entry>1042, 1084, 1086</entry></row><row><entry>AT5G48620.1</entry><entry/><entry/><entry>429, 440, 442,</entry><entry/><entry>558, 609, 610, 632, 658, 659,</entry></row><row><entry/><entry/><entry/><entry>443, 481, 484,</entry><entry/><entry>678, 698, 700, 773, 776, 778,</entry></row><row><entry/><entry/><entry/><entry>485, 486, 487,</entry><entry/><entry>779, 800, 802, 803, 804, 825,</entry></row><row><entry/><entry/><entry/><entry>488</entry><entry/><entry>875</entry></row><row><entry namest="1" nameend="7" align="center" rowsep="1"/></row><row><entry namest="1" nameend="7" align="left" id="FOO-00002">All highly variable amino acids positions (&#x3e;1.5 bit score) are based on reference accessions and are listed according to the protein region in which they are located.</entry></row></tbody></tgroup></table></tables></p><p id="p-0036" num="0031">These highly variable amino acid residues may be modified in order to change the pathogen recognition, specificity, and/or binding of the given plant immunity receptor. <figref idref="DRAWINGS">FIG. <b>4</b></figref> shows the entropy and hydrophobicity of LRRs in RPP1 of <i>A. thaliana</i>, and amino acid modifications that may be made to modify the pathogen recognition, specificity, and/or binding of the receptor. <figref idref="DRAWINGS">FIG. <b>5</b></figref>, <figref idref="DRAWINGS">FIG. <b>6</b></figref>, and <figref idref="DRAWINGS">FIG. <b>7</b></figref> show the entropy and hydrophobicity of LRRs in RPP13 of <i>A. thaliana</i>, and amino acid modifications that may be made to modify the pathogen recognition, specificity, and/or binding of the receptor.</p><p id="p-0037" num="0000">Surface-Exposed Highly Variable Residues Help Predict hvNLR Binding Sites</p><p id="p-0038" num="0032">The variability scores from the alignment of NLR clades afford a residue-resolution view of cross-species diversity of the NLR immune receptors. This information was combined with structure modelling and residue composition analysis to predict ligand-binding sites on the surfaces of highly variable LRR domains. Because the concave side of LRR domains contains a beta-sheet with a regular array of surface exposed residues, it can be represented as a table with one line per repeat unit and the columns corresponding to variable positions in the canonical LXXLXLXX repeat. The representations were used to analyze both sequence variability and residue type composition of RPP1, RPP13, and Sr33. Both the entropy and percent hydrophobic residues over the alignment varied among the surface residues in the NLR. However, there were residues that were both high variable and hydrophobic. Therefore, regions of 10-15 contiguous residues having both highly variable and hydrophobic residues were selected in each receptor to determine whether amino acid modifications therein impact pathogen recognition and binding.</p><p id="p-0039" num="0033"><i>Agrobacterium</i>-mediated transient expression assays in <i>N. benthamiana </i>and protoplast co-transfection assays in <i>Triticum aestivum </i>in the art were used to test the activity of the engineered alleles.</p><heading id="h-0017" level="2">De Novo Identification of New Immune Receptors</heading><p id="p-0040" num="0034">As demonstrated herein, Shannon entropy may be used to analyze plant immune receptors, e.g., predict their binding sites, and predict the receptors that are highly variable. Because innate immune receptors exhibit high variability, Shannon entropy analysis may be used for de novo identification of plant immune receptors. For example, the genomes of a given set of plants may be subjected to Shannon entropy analysis. Sequences that exhibit high variability may be further analyzed using methods in the art to determine if they are part of a gene that encodes a receptor-like protein.</p><p id="p-0041" num="0035">The following examples are intended to illustrate but not to limit the invention.</p><heading id="h-0018" level="1">Examples</heading><p id="p-0042" num="0036"></p><p id="p-0043" num="0000"><tables id="TABLE-US-00003" num="00003"><table frame="none" colsep="0" rowsep="0" pgwide="1" tabstyle="monospace"><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="280pt" align="center"/><thead><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row><row><entry>Sequences</entry></row><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row></thead><tbody valign="top"><row><entry/></row></tbody></tgroup><tgroup align="left" colsep="0" rowsep="0" cols="1"><colspec colname="1" colwidth="280pt" align="left"/><tbody valign="top"><row><entry>Sr33&#x2003;(Uniprot&#x2003;S5DII7_WHEAT,&#x2003;Accession&#x2003;No.&#x2003;AGQ17390.1):</entry></row><row><entry>MDIVTGAIAKLIPKLGELLVGEYKLHKGVKKNIEDLLKELKTMNAALIKIGEVPPDQLDSQDKLW</entry></row><row><entry>ADEVRELSYVIEDAVDKFLVRVHGVEPDDNTNGFKGLMKRTTKLLKKVVDKHGIAHAIKDIKKEL</entry></row><row><entry>QEVAARRDRNKFDGIASIPTEAIDPRLRALYIEAAELVGIYGKRDQELMSLLSLEGDDASTKKLK</entry></row><row><entry>KVSIVGFGGLGKTTLAKAVYEKIKGDFDCHAFVPVGQNPDKKKVFRDILMDLSNSNSDLALLDER</entry></row><row><entry>QLINKLHKFLENKRYLVIIDDVWDEGLWKDINLAFSNRNNLGSRLIITTRIFGVSESCCSSADDP</entry></row><row><entry>VYEIEPLSIDDSSKLFYTRIFSDSGCPKEFEQVSKDILKKCGGVSLAIITIASALASGQQVKPKH</entry></row><row><entry>EWDILLQSLGSGVTKDNSLVEMRRILSFSYYNLPSHLKTCLLYLCIYPEDSMIHRDRLIWKWVAE</entry></row><row><entry>GFVHHGDQGTSLFLVGLNYFNQLINRSMLQPIYSDMGNVYACRVHDMVLDLICNLSHEAKFVNVF</entry></row><row><entry>DGTGNIMSSQSNVRRLSLQNKNEDHQAKPLTNIMSISQVRSITIFPPAVSIMPALSRFEVLRVLD</entry></row><row><entry>LSDCNLGESSSLQPNLKGVGHLIHLRYLGLSGTRISKLPAEIGTLQFLEVLDLGYNHELDELPST</entry></row><row><entry>LFKLRRLIYLNVSPYKVVPTPGVLQNMTSIEVLRGIFVSLNIIAQELGKLARLRELQIYFKDGSL</entry></row><row><entry>DLYEGFVKSLCNLHHIESLIVSCNSGETSFELMDLLGEQWVPPVHLREFVSEMPSQLSALRGWIK</entry></row><row><entry>RDPSHLSNLSELILPTVKEVQQEDVEIIGGLLSLRRLLIESTHQTQRLLVIRADGFRCMVDFYLN</entry></row><row><entry>CGSATQIMFESGALPRAEEVCFSLGVRVAKEDGNRGFDLGLQGNLLSLRRVVWVKMYCGGARVGE</entry></row><row><entry>AKEAKAAVRHALEDHPNHPPIQINMFPRIAEGAQDDDLMCYPVGGPISDAE&#x2003;(SEQ&#x2003;ID&#x2003;NO:</entry></row><row><entry>1)</entry></row><row><entry> </entry></row><row><entry>Sr50&#x2003;(Uniprot&#x2003;A0A0S2LJ10_SECCE,&#x2003;Accession&#x2003;No.&#x2003;ALO61074.1):</entry></row><row><entry>MNIVTGAMGSLIPKLGELLMDEYKLHKRIKKDVEFLKKELESMHAALIKVGEVPRDQLDRQVKLW</entry></row><row><entry>ADEVRELSYNMEDVVDKFLVRVDGDGIQQPHDNSGRFKELKNKMIGLFKKGRNHHRIADAIKEIK</entry></row><row><entry>EQLQEVAARRDRNKVAVPNPMEPITIDPCLRALYAEATELVGIYGKRDEELMRLLSMEGDDASNK</entry></row><row><entry>RLKKVSIVGFGGLGKTTLARAVYDKIKGDFDCRAFVPVGQNPDMKKVLRDILIDLGNPHSDLAIL</entry></row><row><entry>DDKQLVKKLHDFLENKRYLVIIDDIWDEMLWEGINFAFSNRNNLGSRLITTTRNFDVSKSCCLSA</entry></row><row><entry>DDSIYKMKPLSTDDSRRLFHKRIFPDAGGCPSEFQQVSEDILKKCGGVPLAIITIASALASGQHV</entry></row><row><entry>KPKHEWDILLQSLGSGVTKDNSLVEMRRILSFSYYNLPSHLKTCLLYLCIYPEDSTIGRDRLIWK</entry></row><row><entry>WVAEGFVHHGDQGTSLFLVGLNYFNQLINRSMIQPIYDELGQVHACRVHDMVLDLICNFSHEAKF</entry></row><row><entry>VNVLDGTGNSISSQSNVRRLSLQNKMEDHQAKPLTNIMSMSRVRSITIFPPAVSIMPSLSMFEVL</entry></row><row><entry>RVLDLSNCDLGKSSSLQLNLKGVGHLIHLRYLDLQGTQISELPTEIGNLQFLEVLDLDNNYELDE</entry></row><row><entry>LPSTLFKLRRLIYLNVMLYKVVPTPGVLQNMTSIEVLRGVLVSLNIIAQELGNLTRLRELKICFK</entry></row><row><entry>DGNLDSYKLFVKSLGNLHHIESLSISYNSKETSFELMDLLGERWVPPVHLREFVSWMPSQLSALR</entry></row><row><entry>GWIKRDPSHLSNLSELILWPVKEVQQEDVEIIGGLLSLRRLWIKSTHQTQRLLVIRADGFRCMMD</entry></row><row><entry>FELNCGSAAQIMFEPGALPRAEVLVFSLGVRVAQEDGNCGFDLGLQGNLLSLRHDVFVRIYCGGA</entry></row><row><entry>RVGEAKEAEAAVRHALEAHPNHPPIDIEMTPYIAEGARDDDLCEEN&#x2003;(SEQ&#x2003;ID&#x2003;NO:&#x2003;2)</entry></row><row><entry> </entry></row><row><entry>Full&#x2003;length&#x2003;AvrSr50&#x2003;sequence&#x2003;as&#x2003;reported&#x2003;in&#x2003;Chen&#x2003;et&#x2003;al.&#x2003;(2017):</entry></row><row><entry>MMHSIIFQTLLIITIVFSKVWGARSLVKIDWSGSEYTILGANHYEEPNTGAAAQFPGTMTVDDGR</entry></row><row><entry>SPYIVRKLRNSSGKRFYVFTGHPQQPIVWNPHEEIEIQFNRKFLIAVLTEFEADSQVFNHFARRQ</entry></row><row><entry>HR&#x2003;(SEQ&#x2003;ID&#x2003;NO:&#x2003;3)</entry></row><row><entry> </entry></row><row><entry>Cloned&#x2003;AvrSr50&#x2003;(without&#x2003;signal&#x2003;peptide):</entry></row><row><entry>MARSLVKIDWSGSEYTILGANHYEEPNTGAAAQFPGTMTVDDGRSPYIVRKLRNSSGKRFYVFTG</entry></row><row><entry>HPQQPIVWNPHEEIEIQFNRKFLIAVLTEFEADSQVFNHFARRQHR&#x2003;(SEQ&#x2003;ID&#x2003;NO:&#x2003;4)</entry></row><row><entry namest="1" nameend="1" align="center" rowsep="1"/></row></tbody></tgroup></table></tables></p><heading id="h-0019" level="2">Sr50 Binding Site Prediction</heading><p id="p-0044" num="0037">Allelic diversity of the wheat stem rust resistance gene Sr50 was gathered by blast from nr database using Sr50 protein sequence (Accession No. ALO61074.1) as a query. The top 100 hits were aligned full length using PRANK (L&#xf6;ytynoja 2014) and the alignment was edited in Jalview to adjust mis-aligned columns and to remove poorly aligned sequences, resulting in an alignment of 93 sequences. The entropy scores were generated using the Protein Variability Server (imed.med.ucm.es/PVS/). The structural model of Sr50 LRR domain was predicted using PHYRE (Kelley et al. 2015). In Sr50 sequence, 16 LRR motifs were annotated manually and entropy scores as well as hydrophobicity scores for the individual strands of LRRs (LxxLxLxx) were presented in a tabular format. Resulting data was examined for clustering of residues that showed both high entropy scores and the presence of hydrophobic residues resulting in strands 8-14 predicted as the center of the binding site.</p><p id="p-0045" num="0000">Sr3350 Allelic Swap and Transient Co-Expression with AvrSr50 in <i>Nicotiana benthamiana </i></p><p id="p-0046" num="0038">The chimeric protein Sr3350 was constructed by grafting Sr50 leucine-rich repeats residues 8 to 14 onto its ortholog Sr33 (S5DII7_WHEAT) using unique restriction digest sites (BbvCI and SbfI). The binary vector p1776 containing each gene (Sr50, Sr33, Sr3350) was transformed into <i>Agrobacterium </i>strain GV3101 pMP90 by electroporation and inoculated in 4-5 week-old <i>N. benthamianan </i>plants at an OD<sub>600 </sub>of 0.025 with or without the pathogen effector AvrSr50 or its variant race AvrSr50QCMJC (Chen et al. 2017). Four experimental repeats were performed for each experiment on different plants. Phenotypes of the hypersensitive response were recorded two days post infiltration.</p><p id="p-0047" num="0000">Sr3350 Allelic Swap and Cell Death Assays with AvrSr50 in <i>Triticum aestivum </i>(Wheat) Protoplasts</p><p id="p-0048" num="0039">The chimeric Sr3350 construct generated as described above was domesticated and cloned using the Golden Gate cloning method (Engler et al., 2014, ACS Synthetic Biology) into the level 0 acceptor pAGM1287. The genes Sr33 and Sr50 were also domesticated to remove internal restriction sites for the T3 S enzymes Eco31I (BsaI) and BpiI (BbsI) (Thermo Fisher Scientific Waltham, Mass., USA) that are used in the Golden Gate method and cloned into the same vector. Once the correct sequence was confirmed via sequencing the constructs were taken further to the level 1 acceptor pICH47803 with the <i>Zea </i>maize Ubiquitin promoter, a 3&#xd7;FLAG tag, and the Nos (nopaline synthase) terminator from <i>Agrobacterium tumefaciens. </i></p><p id="p-0049" num="0040">For isolation of protoplasts, wheat seeds were grown for two weeks on filter paper under sterile conditions. Once seedlings showed two leaves the epidermis of the leaves was peeled off by making a shallow cut with a razor blade on the abaxial side of the leaf. Peeled leaves were incubated in solution for 3 hours to release wheat protoplasts in the solution. Wheat protoplasts were washed, counted and transfected using PEG4000 (Sigma-Aldrich, St. Louis, Mo.) as described in Saur et al., 2019 Plant Methods 15; 118. After transfection protoplasts were incubated in 12-well plates for two days. After two days the protoplasts were lysed in cell culture lysis buffer (Promega Luciferase Assay System, Catalog number E4550, Promega, San Luis Obispo, Calif.) and transferred to a 96-well cell culture plate (Greiner Bio-One Catalog Number 655075, Greiner Bio-One, Kremsm&#xfc;nster, Austria). The Luciferin substrate (Promega, San Luis Obispo, Calif., see above) was added to each well with a multi-channel pipette and the luminescence was measured in a 96-well plate reader (TECAN Infinite F Plex; 20 minutes, no attenuation).</p><heading id="h-0020" level="2">Data Sources</heading><p id="p-0050" num="0041"><i>Arabidopsis </i>pan-NLRome nucleotide assemblies were downloaded from the 2blades foundation (2blades.org/resources/). Gene annotations were downloaded from GitHub pan-NLRome repository (github.com/weigelworld/pan-nlrome/). The gene models that matched assemblies were available for 62 <i>A. thaliana </i>accessions (Van de Weyer et al. 2019), and these were processed to extract the amino acid sequences of captured protein-coding genes using bedtools getfasta program (Quinlan 2014). The reference set of 168 NLR proteins of the <i>Arabidopsis </i>Col-0 genome was extracted using methods in the art. See, e.g., Sarris et al. 2016.</p><heading id="h-0021" level="2">NLRome Phylogenetic Analysis and Clade Assignments</heading><p id="p-0051" num="0042">Phylogenetic tree construction for the whole <i>A. thaliana </i>NLRome was performed using methods in the art. See, e.g., Bailey et al. 2018. Briefly, amino acid sequences were searched for the presence of NB-ARC domain using hmmsearch and an extended NB-ARC Hidden Markov Model (HMI) 13059_2018_1392_MOESM16_ESM.hmm and initial alignment was made on this HMI using &#x2212;A option. The resulting alignment was processed to convert unaligned characters to gaps using &#x2018;tr a-z-&#x2019; command, and reformatted with &#x2018;esl-reformat&#x2014;migap&#x2019; to remove all gaps followed by &#x2018;esl-alimanip&#x2014;lmin 237&#x2019; command to retained aligned sequences that matched at least 70% of the HMM model. The filtered alignment as well as the alignment not-filtered by HMM coverage were used to construct maximum likelihood phylogenies using raxml (raxml-T 8-n Raxml.out-f a-x 12345-p 12345-#100-m PROTCATJTT-s NLRome.HMMhits.Matches.237 min.fa), which contained 7,818 leaves at 70% HMI coverage and 11,078 leaves, not filtered by HMM coverage. The trees were visualized in iToL. The phylogeny filtered by coverage was used to assign CNL and RNL protein sequences into clades, while the unfiltered phylogeny was used for TNL clade assignment as some clades of TNLs did not contain complete NB-ARCs. To define clades, we first used branch length of &#x3c;0.9 within clade &#x3e;99% bootstrap replicate support followed by grouping remaining sequences based on manual analysis of the phylogeny. Lists of genes from each clade were exported from iToL.</p><heading id="h-0022" level="2">Sequence Alignment and Variability Analysis</heading><p id="p-0052" num="0043">For each identified clade, full length protein sequences were aligned using PRANK algorithm using methods in the art. See, e.g., L&#xf6;ytynoja 2014. The resulting alignments were imported into R and entropy plots were created for individual subclades within RNL, TNL, CNL, NLR-ID and PairedHelper clades using R codes deposited at github.com/krasileva-group/hvNLR. The entropy plots were examined for the presence of a strong baseline (invariant residues). If a baseline was at 0, the clade was not split further, if the baseline was higher indicating the presence of multiple paralogous groups of genes, the clade was passed on to raxml phylogeny construction and sub-clades were constructed as described above. This process was iterated 2-3 times resulting in the final assignment of all genes into sub-clades and construction of final sets of entropy plots. The entropy plots were visually examined and alignments that consistently exceeded 1.5 bits in the LRR regions while maintaining baseline at 0 were marked as highly variable.</p><p id="p-0053" num="0000">Binding Site Prediction in hvNLRs</p><p id="p-0054" num="0044">All highly variable clades were examined for the presence of <i>Arabidopsis </i>Col-0 allele. For these Col-0 alleles, lists of 15 amino acid positions with the highest entropy scores (Table 1) and lists of amino acid positions corresponding to all highly variable residues (bit score &#x3e;1.5) (Table 2) were extracted using HvGenes.R script (github.com/krasileva-group/hvNLR). The second script HvClades.R was used to map entropy scores to the predicted concave surface of the LRR domain. The entropy scores for the individual strands of LRRs (LxxLxLxx) were exported in tabular format. The hydrophobicity scores for these residues were calculated as the percent of hydrophobic residues at a given amino acid position and exported as a second table. Resulting 2D representations of entropy and hydrophobicity of the concave sides were visually examined for clustering of residues that showed both high entropy scores and the presence of hydrophobic residues.</p><p id="p-0055" num="0000">Experiments with Other Plant Species</p><p id="p-0056" num="0045">The methods described herein were used to identify hvNLRs and highly variable amino acid residues in: Brachypodium distachyon (model grass species), <i>Zea </i>maize (maize), <i>Glycine max </i>(soybean).</p><p id="p-0057" num="0000">Screening Modifications of hvNLRs to Derive New Specificities</p><p id="p-0058" num="0046">The methods described herein may be used to design libraries of modified plant immunity receptors. For example, libraries in which the amino acid sites of a given hvNLR are randomized to create up to about 10<sup>8 </sup>variants. The libraries may be screened for a desired activity and a given plant can then be engineered to express the variant immunity receptor that has the desired activity using methods in the art. For example, selected sets of amino acid residues that form a putative ligand binding site may be used for modifications. Library synthesis can be achieved by targeting short regions corresponding to 4-6 LRR repeats containing predicted binding sites and 10-15 top scoring highly variable amino acid residues (bit score &#x3e;1.5) in each region. The library may be screened, e.g., by using a yeast protein binding system, for binding to a given effector protein that is derived from a pathogen of interest. The activity of the hvNLRs may be evaluated in <i>Nicotiana benthamiana </i>and protoplast systems as described above. Plants of interest may be modified to express one or more of the hvNLR variants that bind the given effector protein. The modified plants that exhibit resistance against the pathogen may be further modified and/or propagated.</p><heading id="h-0023" level="1">REFERENCES</heading><p id="p-0059" num="0047">The following references are herein incorporated by reference in their entirety with the exception that, should the scope and meaning of a term conflict with a definition explicitly set forth herein, the definition explicitly set forth herein controls:<ul id="ul0001" list-style="none">    <li id="ul0001-0001" num="0048">Bailey, et al. (2018) Dominant Integration Locus Drives Continuous Diversification of Plant Immune Receptors with Exogenous Domain Fusions. Genome Biology 19 (1): 23.</li>    <li id="ul0001-0002" num="0049">Chen, et al. (2017) Loss of by Somatic Exchange in Stem Rust Leads to Virulence for Resistance in Wheat. Science 358 (6370): 1607-10.</li>    <li id="ul0001-0003" num="0050">Han, et al. (2008) Antigen recognition by variable lymphocyte receptors. Science. 2008 Sep. 26; 321(5897):1834-7.</li>    <li id="ul0001-0004" num="0051">Jehl, et al. (2015) OD-seq: outlier detection in multiple sequence alignments. BMC Bioinformatics. 16, 269-11.</li>    <li id="ul0001-0005" num="0052">Kelley, et al. (2015) The Phyre2 Web Portal for Protein Modeling, Prediction and Analysis. Nature Protocols 10 (6): 845-58.</li>    <li id="ul0001-0006" num="0053">Lagudah, E., Periyannan, S. K., Scientific, C., and Organisation, I. R. (2014) Wheat stem rust resistance gene.</li>    <li id="ul0001-0007" num="0054">Lagudah, E., Periyannan, S., Steuernagel, B., Witek, K., Wulff, B., Two Blades Foundation, Scientific, C., and Organisation, I. R. (2017) Wheat stem rust resistance genes and methods of use.</li>    <li id="ul0001-0008" num="0055">Lagudah, E., Spielmeyer, W., Keller, B., Krattinger, S., Scientific, C., Industrial Research Organization (CSIRO), Research, G., Corp, D., University of Zurich (2011) Resistance genes.</li>    <li id="ul0001-0009" num="0056">L&#xf6;ytynoja, Ari. (2014) Phylogeny-Aware Alignment with PRANK. Methods in Molecular Biology 1079: 155-70.</li>    <li id="ul0001-0010" num="0057">Periyannan, S. K., Dodds, P. N., Mago, R., Lagudah, E., Scientific, C., and Organisation, I. R. (2017) Stem rust resistance gene.</li>    <li id="ul0001-0011" num="0058">Quinlan A R. (2014) BEDTools: The Swiss-Army Tool for Genome Feature Analysis. Curr Protoc Bioinformatics. 47:11.12.1-34.</li>    <li id="ul0001-0012" num="0059">Sarris, et al. (2016) Comparative Analysis of Plant Immune Receptor Architectures Uncovers Host Proteins Likely Targeted by Pathogens. BMC Biology 14 (February): 8.</li>    <li id="ul0001-0013" num="0060">Saur, et al. (2019) A cell death assay in barley and wheat protoplasts for identification and validation of matching pathogen AVR effector and plant NLR immune receptors. Plant Methods 15, 118.</li>    <li id="ul0001-0014" num="0061">Shannon &#x26; Weaver (1949) The Mathematical Theory of Communication, Univ. of Illinois Press. ISBN 0-252-72548-4.</li>    <li id="ul0001-0015" num="0062">Slater &#x26; Birney (2005) Automated generation of heuristics for biological sequence comparison. BMC Bioinformatics. 6, 31-11.</li>    <li id="ul0001-0016" num="0063">Stewart, et al. (1997) A Shannon entropy analysis of immunoglobulin and T cell receptor. Molec Immunol 34(15): 1067-1082.</li>    <li id="ul0001-0017" num="0064">Van de Weyer, et al. (2019) A Species-Wide Inventory of NLR Genes and Alleles in <i>Arabidopsis Thaliana</i>. Cell 178 (5): 1260-72.e14.</li>    <li id="ul0001-0018" num="0065">U.S. Ser. No. 10/113,180B2</li>    <li id="ul0001-0019" num="0066">WO2014194371A1</li>    <li id="ul0001-0020" num="0067">WO2017024053A1</li>    <li id="ul0001-0021" num="0068">WO2017091847A1</li></ul></p><p id="p-0060" num="0069">All scientific and technical terms used in this application have meanings commonly used in the art unless otherwise specified.</p><p id="p-0061" num="0070">The sequences identified by accession numbers and/or Uniprot numbers are herein incorporated by reference in their entirety.</p><p id="p-0062" num="0071">As used herein, a given percentage of &#x201c;sequence identity&#x201d; refers to the percentage of nucleotides or amino acid residues that are the same between sequences, when compared and optimally aligned for maximum correspondence over a given comparison window, as measured by visual inspection or by a sequence comparison algorithm in the art, such as the BLAST algorithm, which is described in Altschul et al., (1990) J Mol Biol 215:403-410. Software for performing BLAST (e.g., BLASTP and BLASTN) analyses is publicly available through the National Center for Biotechnology Information (ncbi.nlm.nih.gov). The comparison window can exist over a given portion, e.g., a functional domain, or an arbitrarily selection a given number of contiguous nucleotides or amino acid residues of one or both sequences. Alternatively, the comparison window can exist over the full length of the sequences being compared. For purposes herein, where a given comparison window (e.g., over 80% of the given sequence) is not provided, the recited sequence identity is over 100% of the given sequence. Additionally, for the percentages of sequence identity of the proteins provided herein, the percentages are determined using BLASTP 2.8.0+, scoring matrix BLOSUM62, and the default parameters available at blast.ncbi.nlm.nih.gov/Blast.cgi. See also Altschul, et al., (1997) Nucleic Acids Res 25:3389-3402; and Altschul, et al., (2005) FEBS J 272:5101-5109. As used herein, an amino acid or nucleotide of a given sequence that &#x201c;corresponds&#x201d; to an amino acid or nucleotide of a reference sequence refers to the amino acid or nucleotide of the given sequence that aligns with the amino acid or nucleotide of the reference sequence when the given sequence and the reference sequence are optimally aligned.</p><p id="p-0063" num="0072">Optimal alignment of sequences for comparison can be conducted, e.g., by the local homology algorithm of Smith &#x26; Waterman, Adv Appl Math 2:482 (1981), by the homology alignment algorithm of Needleman &#x26; Wunsch, J Mol Biol 48:443 (1970), by the search for similarity method of Pearson &#x26; Lipman, PNAS USA 85:2444 (1988), by computerized implementations of these algorithms (GAP, BESTFIT, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, Wis.), or by visual inspection.</p><p id="p-0064" num="0073">As used herein, the terms &#x201c;protein&#x201d;, &#x201c;polypeptide&#x201d; and &#x201c;peptide&#x201d; are used interchangeably to refer to two or more amino acids linked together. Groups or strings of amino acid abbreviations are used to represent peptides. Except when specifically indicated, peptides are indicated with the N-terminus on the left and the sequence is written from the N-terminus to the C-terminus.</p><p id="p-0065" num="0074">Polypeptides may be made using methods known in the art including chemical synthesis, biosynthesis or in vitro synthesis using recombinant DNA methods, and solid phase synthesis. See, e.g., Kelly &#x26; Winkler (1990) Genetic Engineering Principles and Methods, vol. 12, J. K. Setlow ed., Plenum Press, NY, pp. 1-19; Merrifield (1964) J Amer Chem Soc 85:2149; Houghten (1985) PNAS USA 82:5131-5135; and Stewart &#x26; Young (1984) Solid Phase Peptide Synthesis, 2ed. Pierce, Rockford, Ill., which are herein incorporated by reference. Polypeptides may be purified using protein purification techniques known in the art such as reverse phase high-performance liquid chromatography (HPLC), ion-exchange or immunoaffinity chromatography, filtration or size exclusion, or electrophoresis. See, e.g., Olsnes and Pihl (1973) Biochem. 12(16):3121-3126; and Scopes (1982) Protein Purification, Springer-Verlag, NY, which are herein incorporated by reference. Alternatively, the polypeptides may be made by recombinant DNA techniques known in the art. Thus, polynucleotides that encode the polypeptides described herein are contemplated. In some embodiments, the polypeptides and polynucleotides are isolated.</p><p id="p-0066" num="0075">As used herein, an &#x201c;isolated&#x201d; compound refers to a compound that is isolated from its native environment. For example, an isolated polynucleotide is a one which does not have the bases normally flanking the 5&#x2032; end and/or the 3&#x2032; end of the polynucleotide as it is found in nature. As another example, an isolated protein fragment is a one which does not have its native amino acids, which correspond to the full-length polypeptide, flanking the N-terminus, C-terminus, or both.</p><p id="p-0067" num="0076">As used herein, a compound (e.g., receptor) &#x201c;specifically binds&#x201d; a given target (e.g., ligand or epitope) if it reacts or associates more frequently, more rapidly, with greater duration, and/or with greater binding affinity with the given target than it does with a given alternative, and/or indiscriminate binding that gives rise to non-specific binding and/or background binding. As used herein, &#x201c;non-specific binding&#x201d; and &#x201c;background binding&#x201d; refer to an interaction that is not dependent on the presence of a specific structure (e.g., a given epitope). As used herein, an &#x201c;epitope&#x201d; is the part of a molecule that is recognized by, e.g., a receptor. Epitopes may be linear epitopes or three-dimensional epitopes. As used herein, the terms &#x201c;linear epitope&#x201d; and &#x201c;sequential epitope&#x201d; are used interchangeably to refer to a primary structure, e.g., a linear sequence of consecutive amino acid residues, that is recognized by, e.g., a receptor. As used herein, the terms &#x201c;three-dimensional epitope&#x201d; and &#x201c;conformational epitope&#x201d; are used interchangeably to refer a three-dimensional structure, e.g., a plurality of amino acid residues, which need not be consecutive, that together form an epitope.</p><p id="p-0068" num="0077">As used herein, &#x201c;binding affinity&#x201d; refers to the propensity of a compound to associate with (or alternatively dissociate from) a given target and may be expressed in terms of its dissociation constant, Kd. In some embodiments, the antibodies have a Kd of 10<sup>&#x2212;5 </sup>or less, 10<sup>&#x2212;6 </sup>or less, preferably 10<sup>&#x2212;7 </sup>or less, more preferably 10<sup>&#x2212;8 </sup>or less, even more preferably 10<sup>&#x2212;9 </sup>or less, and most preferably 10<sup>&#x2212;10 </sup>or less, to their given target. Binding affinity can be determined using methods in the art, such as equilibrium dialysis, equilibrium binding, gel filtration, immunoassays, surface plasmon resonance, and spectroscopy using experimental conditions that exemplify the conditions under which the compound and the given target may come into contact and/or interact. Dissociation constants may be used determine the binding affinity of a compound for a given target relative to a specified alternative. Alternatively, methods in the art, e.g., immunoassays, in vivo or in vitro assays for functional activity, etc., may be used to determine the binding affinity of the compound for the given target relative to the specified alternative.</p><p id="p-0069" num="0078">Except when specifically indicated, peptides are indicated with the N-terminus on the left and the sequences are written from the N-terminus to the C-terminus. Similarly, except when specifically indicated, nucleic acid sequences are indicated with the 5&#x2032; end on the left and the sequences are written from 5&#x2032; to 3&#x2032;.</p><p id="p-0070" num="0079">As provided herein, amino acid modifications are indicated by the amino acid residue (or residues) and their amino acid position based on the parental polypeptide (i.e., the wildtype or unmutated polypeptide) followed by the specific modification. Amino acid &#x201c;modifications&#x201d; of a given amino acid residue include amino acid substitutions (including non-canonical amino acids), post-translational modifications, chemical modifications, deletion of the given amino acid, and addition of an amino acid before, on, or after the given amino acid. As provided herein, preferred amino acid modifications are amino acid substitutions.</p><p id="p-0071" num="0080">As used herein, the terms &#x201c;subject&#x201d;, &#x201c;patient&#x201d;, and &#x201c;individual&#x201d; are used interchangeably to refer to humans and non-human animals. The terms &#x201c;non-human animal&#x201d; and &#x201c;animal&#x201d; refer to all non-human vertebrates, e.g., non-human mammals and non-mammals, such as non-human primates, horses, sheep, dogs, cows, pigs, chickens, and other veterinary subjects and test animals. In some embodiments, the subject is a mammal. In some embodiments, the subject is a human.</p><p id="p-0072" num="0081">The use of the singular can include the plural unless specifically stated otherwise. As used in the specification and the appended claims, the singular forms &#x201c;a&#x201d;, &#x201c;an&#x201d;, and &#x201c;the&#x201d; can include plural referents unless the context clearly dictates otherwise.</p><p id="p-0073" num="0082">As used herein, &#x201c;and/or&#x201d; means &#x201c;and&#x201d; or &#x201c;or&#x201d;. For example, &#x201c;A and/or B&#x201d; means &#x201c;A, B, or both A and B&#x201d; and &#x201c;A, B, C, and/or D&#x201d; means &#x201c;A, B, C, D, or a combination thereof&#x201d; and said &#x201c;A, B, C, D, or a combination thereof&#x201d; means any subset of A, B, C, and D, for example, a single member subset (e.g., A or B or C or D), a two-member subset (e.g., A and B; A and C; etc.), or a three-member subset (e.g., A, B, and C; or A, B, and D; etc.), or all four members (e.g., A, B, C, and D).</p><p id="p-0074" num="0083">As used herein, the phrase &#x201c;one or more of&#x201d;, e.g., &#x201c;one or more of A, B, and/or C&#x201d; means &#x201c;one or more of A&#x201d;, &#x201c;one or more of B&#x201d;, &#x201c;one or more of C&#x201d;, &#x201c;one or more of A and one or more of B&#x201d;, &#x201c;one or more of B and one or more of C&#x201d;, &#x201c;one or more of A and one or more of C&#x201d; and &#x201c;one or more of A, one or more of B, and one or more of C&#x201d;.</p><p id="p-0075" num="0084">The phrase &#x201c;comprises or consists of A&#x201d; is used as a tool to avoid excess page and translation fees and means that in some embodiments the given thing at issue: comprises A or consists of A. For example, the sentence &#x201c;In some embodiments, the composition comprises or consists of A&#x201d; is to be interpreted as if written as the following two separate sentences: &#x201c;In some embodiments, the composition comprises A. In some embodiments, the composition consists of A.&#x201d;</p><p id="p-0076" num="0085">Similarly, a sentence reciting a string of alternates is to be interpreted as if a string of sentences were provided such that each given alternate was provided in a sentence by itself. For example, the sentence &#x201c;In some embodiments, the composition comprises A, B, or C&#x201d; is to be interpreted as if written as the following three separate sentences: &#x201c;In some embodiments, the composition comprises A. In some embodiments, the composition comprises B. In some embodiments, the composition comprises C.&#x201d; As another example, the sentence &#x201c;In some embodiments, the composition comprises at least A, B, or C&#x201d; is to be interpreted as if written as the following three separate sentences: &#x201c;In some embodiments, the composition comprises at least A. In some embodiments, the composition comprises at least B. In some embodiments, the composition comprises at least C.&#x201d;</p><p id="p-0077" num="0086">To the extent necessary to understand or complete the disclosure of the present invention, all publications, patents, and patent applications mentioned herein are expressly incorporated by reference therein to the same extent as though each were individually so incorporated.</p><p id="p-0078" num="0087">Having thus described exemplary embodiments of the present invention, it should be noted by those skilled in the art that the within disclosures are exemplary only and that various other alternatives, adaptations, and modifications may be made within the scope of the present invention. Accordingly, the present invention is not limited to the specific embodiments as illustrated herein, but is only limited by the following claims.</p><?detailed-description description="Detailed Description" end="tail"?></description><us-sequence-list-doc id="SEQLST-1"><sequence-list file="US20230002781A1-20230105-S00001.XML" carriers="internal-electronic" seq-file-type="ST.25"/></us-sequence-list-doc><us-math idrefs="MATH-US-00001" nb-file="US20230002781A1-20230105-M00001.NB"><img id="EMI-M00001" he="8.13mm" wi="76.20mm" file="US20230002781A1-20230105-M00001.TIF" alt="embedded image " img-content="math" img-format="tif"/></us-math><claims id="claims"><claim id="CLM-00001" num="00001"><claim-text><b>1</b>. A method of modifying pathogen recognition, binding, and/or specificity of a plant immunity receptor, which comprises selecting one or more amino acid residues in the plant immunity receptor that will be modified by<claim-text>determining the Shannon entropy of each amino acid of the plant immunity receptor;</claim-text><claim-text>selecting an entropy cutoff value of at least 1.0, at least 1.1, at least 1.2, at least 1.3, at least 1.4, at least 1.5, at least 1.6, at least 1.7, at least 1.8, at least 1.9, or at least 2.0; and</claim-text><claim-text>selecting at least one amino acid residue amino acid residues among the amino acid residues having the highest entropy values above the entropy cutoff value.</claim-text></claim-text></claim><claim id="CLM-00002" num="00002"><claim-text><b>2</b>. A method of modifying pathogen recognition, binding, and/or specificity of a plant immunity receptor, which comprises<claim-text>modifying (e.g., substituting, deleting, or adding an amino acid before or after) one or more amino acid residues that are identified as having the highest entropy values above the entropy cutoff value.</claim-text></claim-text></claim><claim id="CLM-00003" num="00003"><claim-text><b>3</b>. The method according to <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein the Shannon entropy is determined from a plurality of amino acid sequences from homologs of the plant immunity receptor, and wherein the plant immunity receptor and the homologs are of the same plant species.</claim-text></claim><claim id="CLM-00004" num="00004"><claim-text><b>4</b>. The method according to <claim-ref idref="CLM-00003">claim 3</claim-ref>, wherein the plurality comprises at least 25, at least 30, at least 35, at least 40, at least 45, at least 50, at least 55, at least 60, at least 65, at least 70, at least 75, or at least 80 amino acid sequences.</claim-text></claim><claim id="CLM-00005" num="00005"><claim-text><b>5</b>. The method according to <claim-ref idref="CLM-00003">claim 3</claim-ref>, wherein the plants are genetically diverse.</claim-text></claim><claim id="CLM-00006" num="00006"><claim-text><b>6</b>. The method according to <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein at least ten amino acid residues having the highest entropy values are identified as being likely involved in binding the cognate ligand.</claim-text></claim><claim id="CLM-00007" num="00007"><claim-text><b>7</b>. The method according to <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein 5-20, 6-19, 7-18, 8-16, 9-16, or 10-15 amino acid residues having the highest entropy values are identified as being likely involved in binding the cognate ligand.</claim-text></claim><claim id="CLM-00008" num="00008"><claim-text><b>8</b>. The method according to <claim-ref idref="CLM-00002">claim 2</claim-ref>, and further comprising determining the hydrophobicity of each amino acid of the receptor and identifying one or more of the amino acid residues having the highest entropy values and the highest hydrophobicity as being likely involved in binding the cognate ligand.</claim-text></claim><claim id="CLM-00009" num="00009"><claim-text><b>9</b>. A method of modifying pathogen recognition, binding, and/or specificity of a plant immunity receptor, which comprises modifying one or more amino acid residues that are identified as being involved in binding the cognate ligand of the plant immunity receptor according to <claim-ref idref="CLM-00002">claim 2</claim-ref>.</claim-text></claim><claim id="CLM-00010" num="00010"><claim-text><b>10</b>. The method according to <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein the one or more amino acid residues are substituted with a different amino acid.</claim-text></claim><claim id="CLM-00011" num="00011"><claim-text><b>11</b>. The method according to <claim-ref idref="CLM-00009">claim 9</claim-ref>, wherein a region of contiguous amino acid residues comprising the one or more amino acid residues is substituted with a region of contiguous amino acid residues obtained from a different plant immunity receptor.</claim-text></claim><claim id="CLM-00012" num="00012"><claim-text><b>12</b>. A method of modifying a Sr33 plant immunity receptor, which comprises modifying one or more of the amino acid residues that correspond to amino acid residue positions 703-887 of SEQ ID NO: 1.</claim-text></claim><claim id="CLM-00013" num="00013"><claim-text><b>13</b>. The method according to <claim-ref idref="CLM-00012">claim 12</claim-ref>, wherein the amino acid residue positions are selected from<claim-text>(a) 707, 709, 710, 735, 737, 738, 765, 767, 768, 793, 795, 796, 818, 820, and 821 of SEQ ID NO: 1, or</claim-text><claim-text>(b) 707, 709, 711, 735, 737, 741, 765, 767, 793, 795, 796, 818, 820, 821, 832, 841, 843, 864, 866, and 880 of SEQ ID NO: 1.</claim-text></claim-text></claim><claim id="CLM-00014" num="00014"><claim-text><b>14</b>. The method of <claim-ref idref="CLM-00002">claim 2</claim-ref>, wherein the plant immunity receptor is of <i>Arabidopsis thaliana</i>, and the one or more amino acid residues that are modified correspond the highly variable amino acid residues as set forth in Table 1 or Table 2.</claim-text></claim><claim id="CLM-00015" num="00015"><claim-text><b>15</b>. A plant immunity receptor made by the method according to <claim-ref idref="CLM-00009">claim 9</claim-ref>.</claim-text></claim><claim id="CLM-00016" num="00016"><claim-text><b>16</b>. A nucleic acid molecule which encodes the plant immunity receptor according to <claim-ref idref="CLM-00015">claim 15</claim-ref>.</claim-text></claim><claim id="CLM-00017" num="00017"><claim-text><b>17</b>. A vector comprising the nucleic acid sequence of <claim-ref idref="CLM-00016">claim 16</claim-ref>.</claim-text></claim><claim id="CLM-00018" num="00018"><claim-text><b>18</b>. A cell comprising the vector of <claim-ref idref="CLM-00017">claim 17</claim-ref>.</claim-text></claim><claim id="CLM-00019" num="00019"><claim-text><b>19</b>. A plant comprising the plant immunity receptor of <claim-ref idref="CLM-00015">claim 15</claim-ref>.</claim-text></claim><claim id="CLM-00020" num="00020"><claim-text><b>20</b>. A population of plants comprising a plurality of plants according to <claim-ref idref="CLM-00019">claim 19</claim-ref>.</claim-text></claim></claims></us-patent-application>